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ABSTRACT  
Development of the hypothalamic-pituitary axis requires precise neuronal signaling to 
establish a network that regulates neuroendocrine homeostasis. The anterior lobe (AL) and 
intermediate lobe (IL) of the pituitary are formed from the primordial structure Rathke’s pouch, 
while the posterior lobe (PL) of the pituitary arises from an evagination of the developing 
hypothalamus. The PL contains terminal axons of arginine vasopressin (AVP) neurons from the 
hypothalamic paraventricular nucleus (PVN) and supraoptic nucleus (SON).  
As the pituitary develops, signals from the hypothalamus are necessary for pituitary 
induction and expansion. Little is known about the control of cues that regulate early embryonic 
signaling between the two structures to direct their cell specification. However, we do know that 
ligands and receptors of the Notch signaling pathway, known to control cell specification in other 
contexts, are found both in the hypothalamus and Rathke’s pouch. Additionally, the Notch 
signaling effector gene Hes1 is present in the developing hypothalamus and pituitary and is 
required for proper formation of the pituitary. Therefore, we hypothesized that Hes1 is 
necessary for the generation, placement and projection of AVP neurons.  
To test this hypothesis, we analyzed Hes1 null mice and found that by embryonic day 
16.5 (e16.5) and at e18.5, AVP cell bodies are formed in the SON and PVN, but are abnormally 
placed, suggesting that Hes1 may be necessary for the migration of AVP neurons.  Additionally, 
at e18.5 Hes1 null mice exhibit abnormal AVP axonal projection from the SON and PVN to the 
PL.  Using mass spectrometry to characterize peptide content, we found that Hes1 null 
pituitaries have aberrant somatostatin (SS) peptide, which correlates with abnormal SS cells in 
the pituitary and misplaced SS axon tracts at e18.5.  Our results indicate that Hes1 facilitates 
the migration of hypothalamic neurons, as well as neuropeptide content within the pituitary.  
The effects observed with global Hes1 loss could be due to the action of Hes1 in the 
hypothalamus, Rathke’s pouch or both. To determine the contribution of hypothalamic Notch 
signaling to pituitary organogenesis, we used mice with loss and gain of Notch function 
 iii 
specifically within the developing hypothalamus in cells that express Nkx2.1. We demonstrate 
that loss of Notch signaling by conditional deletion of an important Notch co-factor, Rbpjκ, in the 
hypothalamus (Rbpjκ cKO) does not affect expression of Hes1 within the posterior 
hypothalamus, a region known to influence pituitary development, or expression of the Notch 
effector gene Hes5. In contrast, mice with expression of activated Notch1 intracellular domain 
(NICD) within the hypothalamus (NICD Tg) display ectopic Hes5 expression and increased 
Hes1 expression in the posterior hypothalamus, which is sufficient to cause loss of IL and PL 
structures, and disrupt postnatal pituitary expansion. Additionally, we show that persistent 
hypothalamic Notch activation results in reduced expression of hypothalamic transcription 
factors and morphogens crucial to pituitary development, such as OTX2 and Fgf10, coincident 
with reduced survival of pituitary progenitors. Taken together, our results indicate that Rbpjκ- 
dependent Notch signaling within the developing hypothalamus is not necessary for pituitary 
development, but persistent Notch signaling in hypothalamic progenitors affects pituitary 
induction and expansion.   
 We also observed that Rbpjκ cKO and NICD Tg mice demonstrate significant changes in 
the development of the hypothalamic arcuate nucleus (Arc), found within the anterior 
hypothalamus. The Arc contains proopoiomelanocortin (POMC), neuropeptide Y (NPY) and 
growth hormone releasing hormone (GHRH) neurons, which regulate feeding, energy balance 
and body size. Developmental disruption of this homeostatic mediator underlies diseases 
ranging from growth failure to obesity. Despite considerable investigation regarding function of 
Arc neurons, mechanisms governing their development remain unclear. We found that loss of 
Rbpjκ results in absence of Hes1 but not Hes5 within the primordial Arc at e13.5. At e18.5, 
Rbpjκ cKO mice have few progenitors and increased numbers of differentiated Pomc, NPY and 
Ghrh neurons. In contrast, NICD Tg mice have increased hypothalamic progenitors and 
absence of differentiated Arc neurons. Subsequently, both Rbpjκ cKO and NICD Tg mice have 
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changes in growth and body size during postnatal development. Our results demonstrate that 
Notch/Rbpjκ signaling regulates the generation and differentiation of Arc neurons, which 
contribute to homeostatic regulation of body size.  
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CHAPTER 1: INTRODUCTION 
The vertebrate hypothalamus is a homeostatic regulator of the hypophyseal 
neuroendocrine system through its control of pituitary hormone release.  The discrete 
nuclei compromising the hypothalamus also regulate central and autonomic 
physiological processes and behaviors essential for survival, such as feeding. Together, 
nuclei within the hypothalamus integrate somatic, visceral and behavioral input in order 
to coordinate autonomic and endocrine outflow and maintain homeostasis. 
Developmental defects of this dynamic region are proposed to disrupt regulation of 
hypothalamic neuropeptide release and may contribute to the etiology of multiple 
diseases including obesity, mood disorders and autism (Caqueret, et al. 2005; McGill, et 
al. 2006; Fyffe, et al. 2008; O'Rahilly. 2009). An understanding of how development 
pathways might regulate genes that control differentiation and placement of 
hypothalamic neurons, as well as projection to the pituitary, could help to identify factors 
whose altered expression underlies these disorders.  Studies outlined here will 
specifically address the role of the developmental pathway, Notch signaling, in the 
formation of hypothalamic neurons and proper projection to their neuroendocrine target, 
the pituitary gland.     
Development of the hypothalamus begins with neurogenesis and gliagensis 
between embryonic day 10 (e10.5) and e16.5 in the mouse, as hypothalamic nuclei are 
being formed in an inside-out spatial sequence (Shimada, Nakamura. 1973). Certain 
neurons migrate laterally and form the supraoptic nucleus (SON), while neurons that 
migrate medially form the arcuate nucleus (Arc), ventromedial hypothalamus (VMH) and 
paraventricular nucleus (PVN) by e14.5 (Altman, Bayer. 1978; Bayer, Altman. 1987).  
Specific transcription factors that are necessary for specification of distinct 
neuroendocrine cell types within dorsal, lateral and ventral hypothalamic nuclei have 
been identified.  For example, the transcription factors Otp, Brn2, Sim1, Sim2 and Anrt2 
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are necessary for the development and specification of dorsal nuclei such as the PVN 
and lateral nuclei such as the SON (Nakai, et al. 1995; Schonemann, et al. 1995; 
Michaud, et al. 1998; Acampora, et al. 1999b; Michaud, et al. 2000; Wang, Lufkin. 2000; 
Hosoya, et al. 2001; Goshu, et al. 2004).  
Expression of Nkx2.1 is necessary for specification of the ventral hypothalamus 
(Marin, Anderson, Rubenstein. 2000), including the Arc and VMH. Mash1 is necessary 
for Arc and VMH formation (McNay, et al. 2006), and promotes expression of Gsh1, a 
transcription factor required for growth hormone releasing hormone (GHRH) expression 
within the Arc (Li, et al. 1996). Ngn3 is required for proper proopiomelanocortin (POMC) 
and neuropeptide-Y (NPY) neuron development in the Arc (Pelling, et al. 2011). 
Additionally, Otp is necessary for proper formation of Arc somatostatin (SS) neurons 
(Acampora, et al. 1999a). SF-1 is a transcription factor only expressed within the VMH 
and its expression is required for the proper placement of neurons within the nucleus 
(Davis, et al. 2004a). Islet-1 (Isl-1) is another transcription factor localized specifically to 
the VMH, and is expressed in developing VMH neurons (Davis, et al. 2004b).  
Specific spatial and temporal expression of these transcription factors is 
necessary for proper formation and function of magnocellular and parvocellular neurons 
within the hypothalamus (Fig. 1.1; Zhu, Gleiberman, Rosenfeld. 2007). Magnocellular 
neurons located in the PVN and SON release arginine vasopressin (AVP) and oxytocin 
(OT) from their axonal terminals within the posterior lobe of the pituitary.  OT acts on the 
periphery by inducing lactation and uterine contraction through prolactin (PRL) release 
from the pituitary.  Within the central nervous system, OT facilitates social behavior, 
including parental care, social recognition and bonding. AVP also has central effects on 
behavior, including social learning, memory and aggression (Lim, Young. 2006; 
Heinrichs, von Dawans, Domes. 2009).  Within the posterior pituitary, AVP action is 
crucial to nutrient and water reabsorption.  
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Hypothalamic parvocellular neurons project to the median eminence (ME) and 
release hormones that travel through the hypophyseal portal vasculature to act on cells 
within the anterior pituitary.  Parvocellular neurons in the PVN release corticotrophin-
releasing hormone (CRH) and thyrotrophin-releasing hormone (TRH).  CRH acts on 
corticotropes in the anterior lobe that secrete adrenocorticotrophic hormone (ACTH), 
which regulates metabolic function through stimulation of glucocorticoid synthesis in the 
adrenal gland.  TRH acts on thyrotropes, which produce thyroid-stimulating hormone 
(TSH) in order to facilitate thyroid follicle development and thyroid hormone (TH) 
secretion, and additionally modulate skeletal remodeling.   
The hypothalamic anterior periventricular (aPV) nucleus contains parvocelluar 
SS releasing neurons, while GHRH are found in the Arc.  GHRH activates secretion of 
somatotropes in the anterior pituitary, which secrete growth hormone (GH) and regulate 
linear growth and metabolism.  Conversely, SS inhibits the secretion of GH as well as 
TRH. Release of SS into the anterior lobe is crucial to inhibit GH release and 
dysregulation of this circuit can result in pituitary adenomas (de Bruin, et al. 2009; 
Tateno, et al. 2009).   
Differentiated neuroendocrine neurons within the ventrally located Arc include 
these GHRH, SS neurons as well as dopaminergeric tyrosine hydroxlyase (Th) neurons.   
GHRH, SS and TH neurons project to the ME, a structure that forms the base of the third 
ventricle, where they release hormone and dopamine to regulate anterior pituitary 
function.  Regulation of the feeding circuit is also controlled by the ventral hypothalamus, 
specifically neurons within Arc and VMH. Through the help of tanycytes, hypothalamic 
support cells, neurons within these nuclei detect peripheral hormones, such as leptin 
produced by adipose tissue, and regulate appetite and feeding behavior accordingly. 
Specifically, leptin inhibition of orexigenic NPY neurons in the Arc signals the PVN to 
stimulate food intake, while leptin activates anorexigenic POMC neurons in the Arc to 
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suppress food intake through PVN signaling.  
VMH is also involved in feeding behavior and energy balance, as well as sexual 
behavior (Canteras, Simerly, Swanson. 1994). In fact, disruptions of VMH development 
can lead to obesity in adulthood (Majdic, et al. 2002). Neurons within the VMH are 
characterized by expression of certain transcription factors, receptors and 
neuropeptides, including: SF-1, ERα, nNos, GABAARα1, GAD65/67, Isl-1, NPY, BDNF 
and COUP-TF1 positive neurons (McClellan, Parker, Tobet. 2006). Importantly, although 
initial studies have identified specific transcription factors that are present and required 
for formation of hypothalamic neurons, pathways that regulate specification, 
differentiation and subsequent nuclei formation remain unclear.   
Once hypothalamic neurons are formed within their respective nuclei, they must 
send dendritic and axonal projections to other regions within and outside the 
hypothalamus in order to regulate essential physiological behaviors. Processes such as 
stress, growth and reproduction are controlled by hypophyseal neuroendocrine neurons, 
which send their axons to terminate in the ME and posterior pituitary. The 
neuroendocrine hypothalamus therefore controls the pituitary directly, through OT and 
AVP peptide secretion into the general circulation from the posterior pituitary, as well as 
indirectly through secretion of neuropeptide from CRH, TRH, SS, GHRH neurons into 
local portal circulation in the ME. The ME is a complex structure, containing a plexus of 
looped fenestrated capillaries where axons projected from hypothalamic neuroendocrine 
cells terminate. Blood flows from the ME into a secondary portal venous system, which 
carries neuropeptides from the hypothalamic neurons to the anterior pituitary to regulate 
endocrine function. 
Proper targeting of neuroendocrine axons to the ME and posterior pituitary during 
development is crucial to hypothalamic-pituitary function. In fact, disruption of functional 
AVP release from the posterior pituitary is associated with central diabetes insipidus 
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(DI). Cases of inherited central DI are associated with mutations that result in faulty AVP 
peptide processing, however, 50% of central DI cases are due to unknown causes (Ito, 
Jameson, Ito. 1997; Siggaard, et al. 1999; Maghnie, et al. 2000).  Other causes are likely 
to involve developmental disruption of the hypothalamic-pituitary axis, specifically 
disruption of successful projection of AVP neurons to their target, the posterior pituitary. 
Connections between the hypothalamus and its neuroendocrine targets, the ME 
and pituitary begin early in embryonic development. Successful axonal projection from 
neurons in hypothalamic nuclei to the ME and pituitary is likely dependent on cross-talk 
between the two structures during embryonic development (Gutnick, et al. 2011). In fact, 
magnocellular neurons, parvocellular neurons and the primordial pituitary cells 
demonstrate striking temporal and spatial coordination in signaling events that regulate 
their differentiation.  All are formed from the embryonic basal plate, with the anterior 
ridge giving rise to the anterior pituitary, and the adjacent region giving rise to the 
hypothalamus and the posterior pituitary (Treier, Rosenfeld. 1996; Burrows, et al. 1999b; 
Zhu, Gleiberman, Rosenfeld. 2007). The endocrine hypothalamus is specified from 
proliferative neuroepithelium as it provides cues to neighboring pituitary cells in the oral 
ectoderm.  
Previous studies have delineated the importance of signaling factors such as 
Shh, BMP, Fgf and Wnt proteins in hypothalamic-pituitary development. Importantly, 
signaling molecules derived from the primordial endocrine hypothalamus are necessary 
to induce formation of the primordial pituitary, a structure called Rathke’s pouch (Dale, et 
al. 1997; Lee, et al. 2006; Manning, et al. 2006; Rizzoti, Lovell-Badge. 2007; Ohyama, 
Das, Placzek. 2008). Rathke’s pouch invaginates from the oral ectoderm at e8.5 in 
mouse and develops into the anterior and intermediate pituitary gland (Burrows, et al. 
1999a; Zhu, Rosenfeld. 2004). Evidence for the essential role of hypothalamic signaling 
in Rathke’s pouch formation is apparent in studies where mutations in Bmp4, Fgf8, Fgf4, 
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Nkx2.1, Wnt5a and Sox3 genes result in improper pouch induction (Dale, et al. 1997; 
Lee, et al. 2006; Manning, et al. 2006; Rizzoti, Lovell-Badge. 2007; Ohyama, Das, 
Placzek. 2008). For example, deletion of Sox3, expressed specifically in the developing 
hypothalamus and restricted from the pituitary, results in an expanded and bifurcated 
Rathke’s pouch, and reduction in pituitary hormones (Rizzoti, Lovell-Badge. 2007). 
Importantly, SOX3 gene mutations have also been reported in patients who present with 
hypopituitarism (Kelly, et al. 1988; Carvalho, et al. 2003; di Iorgi, et al. 2009). Taken 
together, these data suggest that extrinsic hypothalamic signals are necessary for 
proper pituitary development in mice and humans.  
Studies have indicated that extrinsic hypothalamic signals allow for proper 
pituitary induction through activation of transcription factors, such as Hesx1, which is 
present in both the developing hypothalamus and pituitary (Chou, et al. 2006). Hesx1 
allows for specification and proper differentiation of cells within Rathke’s pouch (Gaston-
Massuet, et al. 2008). In humans, mutations in HESX1 can lead to human septo-optic 
dysplasia (1:10,000), characterized by midline forebrain abnormalities, optic nerve 
hypoplasia and hypopituitarism. Many of these patients also present with an ectopic 
posterior pituitary (EPP; Patel, et al. 2006). Because the posterior pituitary is a direct 
target for hypothalamic neurons later in development, the presence of ectopic placement 
associated with HESX1 mutations indicates that this gene may be involved in cross-talk 
that allows for proper hypothalamic axon pathfinding.  
Intrinsic transcription factors expressed within Rathke’s pouch, which are 
necessary for organogenesis and proper pituitary cell differentiation, have been 
identified. For example, early expression of Lhx3 and Lhx4 is necessary for pouch 
expansion and pituitary organogenesis (Raetzman, Ward, Camper. 2002; Ellsworth, 
Butts, Camper. 2008). LHX4 gene mutations have also been reported in patients with 
hypopituitarism and EPP (Kelly, et al. 1988; Carvalho, et al. 2003; di Iorgi, et al. 2009). In 
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mice, these transcription factors are necessary for proper specification of terminally 
differentiated pituitary cells types: corticotropes (ACTH), thyrotropes (TSH), somatropes 
(GH), lactotropes (PRL), gonatropes (FSH, LH), and melanotropes (MSH). Additional 
transcription factors, Prop1 and Pit1, need to be sequentially expressed within Rathke’s 
pouch to form and expand thyrotrope, somatotrope and lactotrope cell lineages within 
the AL (Camper, et al. 1990; Li, et al. 1990; Sornson, et al. 1996). Prop1 mutations 
identified in Ames dwarf mutant mice (Prop1df/df), result in pituitary hypoplasia and 
reduction in pituitary hormone producing cells (Tang, et al. 1993; Sornson, et al. 1996). 
Importantly, several PROP1 mutations have been identified in humans with multiple 
pituitary hormone deficiency (MPHD; Wu, et al. 1998; Abrao, et al. 2006). 
There is also evidence that signals from the developing pituitary primordium 
(Shh, Bmp2, Wnt4; Alatzoglou, Dattani. 2009) can affect hypothalamic development. In 
fact, Ames dwarf mice with Prop1 mutations have alterations in mRNA expression of 
hypothalamic neurons that regulate growth, including GHRH and SS neurons (Hurley, 
Wee, Phelps. 1997; Hurley, Wee, Phelps. 1998). Additionally, studies have identified an 
inducible element in Hesx1 that is activated within the developing hypothalamus as a 
result of physical contact with the adjacent Rathke’s pouch (Hermesz, Williams-Simons, 
Mahon. 2003). Taken together with other data, induction of Rathke’s pouch relies on 
signaling from the hypothalamus, and continued development of hypothalamus is 
dependent on factors present within pituitary primordium. Therefore, the pituitary, an 
eventual target of hypothalamic neurons, also directs the proper development of 
hypothalamic neurons. However, the molecular mechanisms responsible for these 
unique reciprocal inductive interactions remain unknown.  
We do know that Notch signaling is active in both the developing hypothalamus 
and pituitary during induction and differentiation of these organs. Prop1 is a target of the 
Notch signaling pathway, which is an important regulator of cell differentiation, and 
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activation of Prop1 expression through sustained Notch signaling is required for 
specification of pituitary cell types (Raetzman, et al. 2004; Zhu, et al. 2006). In humans, 
PROP1 mutations account for only some cases of MPHD, and it is possible that Notch 
signaling plays an important role in pituitary formation through activation of transcription 
factors such as Prop1.  Although previous studies have implicated how extrinsic signals 
from the hypothalamus affects proper pituitary development, relatively little is known 
regarding how early pituitary development shapes hypothalamic development, including 
proper formation and projection of hypothalamic neurons to the pituitary. We 
hypothesize that the Notch signaling pathway is necessary and sufficient for proper 
specification, placement and projection of neurons within hypothalamic nuclei such as 
the PVN, SON, Arc and VMH.  
Notch signaling is an evolutionarily conserved signaling system that is important 
for cellular differentiation.  The transmembrane receptor Notch interacts with its ligand 
(Delta/Jagged) on a neighboring cell, which results in the cleavage of the Notch 
intracellular domain (NICD).  The NICD then binds to RBPJ in the nucleus where Hes 
and Hey genes are activated.  Hes proteins generally act as transcriptional repressors, 
which block the function of basic hoop loop helix (bHLH) transcriptional activators (Fig. 
1.2; Kageyama, et al. 2008).   
Mammalian genomes encode multiple homologs for the Notch receptor (Notch 1, 
2, 3, 4) and its ligands (Delta-like 1, 3, 4, Jagged1 and Jagged2).  Expression of these 
genes is spatially and temporally restricted during embryogenesis, consistent with the 
observation that Notch signaling controls differentiation in many tissues.  In fact, Notch 
mutations in humans lead to developmental disorders.  For example, mutations in 
NOTCH3 result in cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL; Joutel, et al. 1996).  Alagille syndrome (AGS) is 
another Notch related disease, caused by mutation of JAGGED1.  AGS patients suffer 
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from variable phenotypes, including growth failure and delayed pubertal development, 
indicating involvement of the hypothalamic-pituitary axis (Wasserman, et al. 1999; 
Quiros-Tejeira, et al. 2000).  
Notch receptors regulate cell differentiation, which occurs when there is an 
asymmetric expression of Notch receptors and ligands within a population of equivalent 
precursor cells.  Notch signaling has been shown to play a crucial role in neurogenesis 
in both embryonic and adult brains (Chambers, et al. 2001; Mason, et al. 2005; 
Androutsellis-Theotokis, et al. 2006; Mizutani, et al. 2007; Yoon, et al. 2008). In the 
cerebellum, loss of Notch1 results in the premature differentiation of neurons at the 
expense of undifferentiated cells (Lutolf, et al. 2002) and persistent activation of Notch2 
maintains precursors in a proliferative state (Solecki, et al. 2001).   Similarly, Hes1 and 
Hes3 double null mice show premature neuron formation in the isthmus of the mid/hind 
brain and subsequent loss of midbrain and anterior hindbrain structures (Hirata, et al. 
2001).  Additionally, if Hes1 is overexpressed in the telencephalon, neuronal 
differentiation is inhibited (Ohtsuka, et al. 2001).  Additional studies have shown that 
Notch signaling activation leads to maintenance of neural stem cells within the 
developing brain, while Notch inactivation induces neuronal differentiation and depletes 
neural stem cells (Bertrand, Castro, Guillemot. 2002; Kageyama, et al. 2008; Kopan, 
Ilagan. 2009). 
The Notch effector gene Hes1 is expressed in the pituitary and hypothalamus in 
the same regions as the Notch receptors in mouse. Additionally, Hes1 is expressed in 
both of these developing structures in a temporally and spatially restricted pattern (Fig. 
1.3 ;Raetzman, Cai, Camper. 2007). Hes1 null mice show a reduction in size of the 
posterior pituitary, which contains terminal axons of magnocellular AVP and OT neurons. 
These data suggest that Hes1 may be necessary for AVP and OT neuron formation and 
projection to the posterior lobe, or for posterior lobe formation itself.  
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Notch signaling has a well-established role in establishing cell identity, and in the 
central nervous system, the identity of a neuron includes its target.  In fact, Notch 
signaling has been shown to play a role in axonal targeting within the cerebral cortex 
and hippocampus in conjunction with the extracellular matrix molecule Reelin (Alcantara, 
et al. 1998; Sibbe, et al. 2009).  Reelin-deficient mice have reduced levels of cleaved 
NICD, and loss of Notch signaling results in faulty neuronal migration.  Furthermore, 
overexpression of NICD mitigates cortical neuronal migration defects associated with 
Reelin null mice (Hashimoto-Torii, et al. 2008). Reelin mRNA is also expressed in the 
primordial PVN, SON and aPV during embryonic development (Alcantara, et al. 1998), 
although its relationship with members of the Notch signaling pathway during 
hypothalamic development is unclear. Given the role of Notch signaling in axon 
migration within the cerebral cortex and hippocampus, I hypothesize that Notch signaling 
may influence the targeting of neurons from the hypothalamus to the pituitary.   
Neuroendocrine peptides are formed by a combination of the conditions within 
the vesicle and specific enzymes that cleave prohormones.  Two enzymes, prohormone 
convertase 1/3 (PC1/3) and prohormone convertase 2 (PC2) are present in the 
hypothalamus and pituitary and are necessary for cleavage of most neuroendocrine 
prohormones.  Both PC1/3 and PC2 are co-expressed with pro-OT and pro-AVP in the 
SON and PVN (Dong, et al. 1997).  Within the pituitary, PC2 is present in the 
intermediate lobe (IL) and cleaves POMC into αMSH.  Previous studies have shown 
mice lacking the Notch effector gene Hes1 display an absence of PC2 expression in the 
IL with coincident loss of αMSH (Raetzman, Cai, Camper. 2007), indicating a possible 
role of Notch signaling in proper peptide processing. Based on this data I hypothesize 
that peptide processing of AVP neurons, controlled by PC2 in the PVN and SON, may 
also be altered in Hes1 null mice.  Importantly, in humans, pro-AVP and pro-OT 
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processing is impaired in patients with Prader-Willi or Wolfram’s syndrome, concomitant 
with PC2 deficits (Swaab, Purba, Hofman. 1995; Gabreels, et al. 1998). Other signaling 
pathways crucial for early embryonic development, such as FGF signaling, result in 
disruption of neuropeptide processing. Homozygous Fgf8 hypomorphic mice show 
deficiency in post-translational processing and cleavage of the OT prohormone found in 
neurons of the PVN and SON (Brooks, Chung, Tsai. 2010). Taken together with 
previous studies utilizing Hes1 null mice, these data indicate that Notch signaling may 
directly or indirectly play a role in proper peptide processing within hypothalamic neurons 
and possibility functional delivery of neuropeptide to the pituitary.   
It is clear that coordinated development of the hypothalamus and pituitary is 
necessary for the formation and proper function of the hypothalamic-pituitary axis. Based 
on previous data, we hypothesize that Notch signaling is necessary and sufficient for 
proper formation of hypothalamic neurons within the PVN, SON, Arc and VMH, as well 
projection of neuroendocrine neurons within these nuclei to their target, the pituitary 
gland. In order to address this hypothesis, studies outlined here characterize the 
hypothalamic development and projection of magnocellular neurons within the Hes1 null 
mouse (Chapter 2).  Additionally, we have investigated if Notch signaling is sufficient for 
the early embryonic development of the hypothalamic-pituitary axis (Chapter 3), and 
required hypothalamic neuron formation (Chapter 4) in transgenic mice with loss and 
gain of Notch signaling function specifically within the hypothalamus.  
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Fig. 1.1. An overview of the hypothalamic-pituitary axis and central parvocellular 
feeding circuitry. The magnocellular neurosecretory system includes neurons in 
paraventricular hypothalamus (PVN) and supraoptic nucleus (SON) that synthesize 
oxytocin (OT) and arginine vasopressin (AVP) and release them from axonal terminals in 
the posterior lobe (P). Hormone synthesis and secretion in the anterior lobe of pituitary 
(A) are regulated by releasing factors produced by the parvocellular neurons and 
released into the portal vascular system. Corticotropin releasing hormone (CRH) and 
thyrotropin releasing hormone (TRH) are synthesized by neurons in the PVN. Growth 
hormone releasing hormone (GHRH) is synthesized by neurons of the arcuate nucleus 
(Arc). Somatostatin (SS) is mainly synthesized by neurons in anterior periventricular 
nucleus (aPV). The parvocellular neurosecretory neurons project to the medial eminence 
where they release hormones that are transported to the anterior pituitary by the portal 
vascular system. Main regulators of hypothalamic feeding circuitry include parvocellular 
neurons proopiomelanocortin (POMC) and neuropeptide-Y (NPY) within the Arc that 
project to the PVN, as well as NPY and steroidiogenic factor 1 (SF-1) neurons with the 
ventromedial hypothalamus (VMH). Modified from Zhu et al., 2007. 
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Fig. 1.2. Schematic of the Notch Signaling pathway. The proneural genes Mash1 and 
Ngn2 induce expression of Notch ligands (Delta-like 1, 3, 4, Jagged1 and Jagged2), 
which activate Notch signaling in neighboring cells through activation of Notch receptors 
(Notch 1, 2, 3, 4). Upon activation, the Notch intracellular domain (NICD) is released 
from the transmembrane region and transferred to the nucleus, where it forms a complex 
with RBPj and induces Hes1 and Hes5 expression. Hes1 and Hes5 proteins then 
repress proneural gene expression. Modified from Kageyama et al., 2008. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 20 
 
)LJXUH+HVP51$LVH[SUHVVHGLQWKHGHYHORSLQJSLWXLWDU\5DWKNH¶VSRXFK
53DQGGHYHORSLQJK\SRWKDODPXV+\SLQDWHPSRUDOO\DQGVSDWLDOO\UHVWULFWHG
SDWWHUQDWH$DQGH%+HVP51$H[SUHVVLRQGHFUHDVHVDWH
&DQGLVQRWGHWHFWDEOHE\H'
53 53 53
53
+\S +\S
+\S
+\S
 
Fig. 1.3. Hes1 mRNA is expressed in the developing pituitary (Rathke’s pouch; RP) 
and the developing hypothalamus (Hyp). Expression is found in temporally and 
spatially restricted pattern at e10.5 (A) and e11.5 (B). Hes1 mRNA expression 
decreases at e14.5 (C) and is not detectable at e16.5 (Raetzman et al., 2007). 
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CHAPTER 2: THE NOTCH EFFECTOR GENE HES1 REGULATES MIGRATION OF 
HYPOTHALAMIC NEURONS, NEUROPEPTIDE CONTENT AND AXON TARGETING 
TO THE PITUITARY1 
 ABSTRACT  
Proper development of the hypothalamic-pituitary axis requires precise neuronal 
signaling to establish a network that regulates homeostasis.  The developing 
hypothalamus and pituitary utilize similar signaling pathways for differentiation in 
embryonic development. The Notch signaling effector gene Hes1 is present in the 
developing hypothalamus and pituitary and is required for proper formation of the 
pituitary, which contains axons of arginine vasopressin (AVP) neurons from the 
hypothalamic paraventricular nucleus (PVN) and supraoptic nucleus (SON).  We 
hypothesized that Hes1 is necessary for the generation, placement and projection of 
AVP neurons. We found that Hes1 null mice show no significant difference in cell 
proliferation or death in the developing diencephalon at embryonic day 10.5 (e10.5) or 
e11.5.  By e16.5, AVP cell bodies are formed in the SON and PVN, but are abnormally 
placed, suggesting that Hes1 may be necessary for the migration of AVP neurons.  
GAD67 immunoreactivity is ectopically expressed in Hes1 null mice, which may 
contribute to cell body misplacement.  Additionally, at e18.5 Hes1 null mice show 
continued misplacement of AVP cell bodies in the PVN and SON and additionally exhibit 
abnormal axonal projection.  Using mass spectrometry to characterize peptide content, 
we found that Hes1 null pituitaries have aberrant somatostatin (SS) peptide, which 
                                                
1 This chapter appeared in its entirety in Developmental Biology and is reffered to later in this dissertation as 
“Aujla et al., 2011”. Aujla, P.K., Bora, A., Monahan, P., Sweedler, J.V., Raetzman, L.T., 2011. The Notch 
Effector Gene Hes1 Regulates Migration of Hypothalamic Neurons, Neuropeptide Content and Axon 
Targeting to the Pituitary. Dev Biol 353, 61-71. This article is reprinted with the permission of the publisher 
and is available from http://www.elsevier.com and using DOI: 10.1016/j.ydbio.2011.02.018 
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correlates with abnormal SS cells in the pituitary and misplaced SS axon tracts at e18.5.  
Our results indicate that Notch signaling facilitates the migration and guidance of 
hypothalamic neurons, as well as neuropeptide content.   
 
INTRODUCTION 
The hypothalamic-pituitary axis (HP) is a master controller of endocrine 
processes, such as metabolism, growth and reproduction.  The neuroendocrine 
hypothalamus contains nuclei with two distinct neuronal populations: magnocellular and 
parvocellular. Magnocellular neurons located in the paraventricular nuclei (PVN) and the 
supraoptic nuclei (SON) release arginine vasopressin (AVP) and oxytocin (OT) from 
their axonal terminals within the posterior lobe (PL) of the pituitary.  OT acts on the 
periphery by inducing lactation and uterine contraction.  In the central nervous system, 
OT facilitates social behavior, including parental care and bonding (Lim, Bielsky, Young. 
2005; Lim, Young. 2006). AVP also exerts central effects on behavior, including 
aggression (Heinrichs, von Dawans, Domes. 2009). AVP released from the PL is crucial 
to nutrient reabsorption and regulating the body’s response to stress.  
The hypothalamic anterior periventricular (aPV) nucleus contains parvocellular 
somatostatin (SS)-releasing neurons, and growth hormone-releasing hormone (GHRH) 
neurons are found in the arcuate nucleus (ARN).  GHRH activates secretion of 
somatotropes in the anterior lobe of the pituitary (AL).  Somatotropes secrete growth 
hormone (GH) and promote linear growth and metabolism, and SS inhibits the secretion 
of GH to regulate this process.  
Magnocellular neurons, parvocellular neurons and pituitary cells demonstrate 
striking temporal and spatial coordination in events that regulate their differentiation.  
These cells form from the embryonic basal plate, with the anterior ridge generating the 
AL, and the adjacent region developing into the hypothalamus and the PL (Couly, 
 23 
 
Douarin. 1987, Couly, Douarin. 1988, Kawamura, Kikuyama. 1995, Kouki et al. 2001).  
In the mouse, hypothalamic neurons are generated between e10.5 and e12.5 from the 
proliferative neuroepithelium of the third ventricle (Shimada, Nakamura. 1973). Several 
signaling pathways and transcription factors have been implicated in formation of these 
neurons in the PVN and SON (Michaud, et al. 1998; Michaud, et al. 2000; Hosoya, et al. 
2001). From the neuroepithelium, neurons migrate laterally to form the SON, or medially 
to form the PVN and aPV by e14.5 (Altman, Bayer. 1978; Altman, Bayer. 1979; Bayer, 
Altman. 1987). Various guidance cues, specifically, members of the Netrin, Slit/Robo 
and Semaphorin/Plexin/Neuropilin families are expressed in and around the developing 
PVN and SON, and have been implicated in cell migration (Deiner, Sretavan. 1999; Xu, 
Fan. 2007; Xu, Fan. 2008). GABAergic neurons have also been implicated in proper 
boundary formation of the PVN and VMN regions of the hypothalamus during 
development through GABAA and GABAB receptors (Dellovade, et al. 2001; Davis, 
Henion, Tobet. 2002; McClellan, Calver, Tobet. 2008; McClellan, Stratton, Tobet. 2010).  
Although initial studies have begun to identify factors that are generally required 
for formation and migration of hypothalamic neurons, the mechanisms regulating specific 
neuroendocrine cell development remain unclear. We hypothesize that the Notch 
signaling pathway is required for proper formation, migration and projection of AVP and 
SS neurons to the pituitary.   
Notch signaling is an evolutionarily conserved mechanism that guides progenitor 
maintenance and cell specification in the developing nervous system.  In the cerebellum, 
loss of Notch1 results in the premature differentiation of neurons at the expense of 
undifferentiated cells (Lutolf, et al. 2002), and persistent activation of Notch2 maintains 
precursors in a proliferative state (Solecki, et al. 2001). Similarly, Hes1 and Hes3 double 
null mice show premature neuron formation in the mid/hind brain and subsequent loss of 
midbrain and anterior hindbrain structures (Hirata, et al. 2001). Additionally, 
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overexpression of Hes1 in the telencephalon inhibits neuronal differentiation (Ohtsuka, 
et al. 2001).  
Previous studies have delineated the importance of the Notch pathway in early 
specification events that regulate cell fate in the developing HP.  The Notch effector 
gene Hes1 is spatially and temporally restricted to the developing diencephalon and 
pituitary during development, and its expression must be silenced for pituitary cell 
differentiation to occur (Zhu, et al. 2006; Kita, et al. 2007; Raetzman, Cai, Camper. 
2007). Hes1 null mice survive until embryonic day 18.5 (e18.5) and show a reduction in 
PL size (Raetzman, Cai, Camper. 2007; Himes, Raetzman. 2009), which contains 
terminal axons of AVP and OT neurons. Previous studies have shown that the 
development of the ventral diencephalon (VD) also relies on Hes1, with Hes1 null mice 
displaying hypoplastic phenotypes of the developing pituitary and diencephalon 
(Akimoto, et al. 2010). Importantly, there is emerging evidence implicating Hes1 in cell 
migration and cell placement in the developing pituitary (Himes, Raetzman. 2009). Given 
that the primordial pituitary and hypothalamus share signaling pathways that generate 
differentiation and migration cues, it is likely that Hes1 may play a role in the 
development and placement of endocrine neurons within the hypothalamus.  
In order to address the extent that Notch signaling is required for functional 
neuronal development within the HP, we analyzed Hes1 null mice and control littermates 
at various stages of embryonic development. We found no significant difference in the 
number of proliferating cells or cell death in the VD.  AVP cell bodies are specified in 
Hes1 null mice and aberrantly placed, which correlates with ectopic GAD67 expression 
within these regions. We found abnormal projections of AVP-positive axons to the PL in 
Hes1 null mice. Additionally, we utilized mass spectrometry-based peptidomics (Li, 
Sweedler. 2008) to screen for peptide alterations in Hes1 null pituitaries at e18.5.  We 
uncovered AVP-related products in Hes1 null mice as well as an unexpected SS peptide 
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content. Further analyses showed a reduction of SS-positive cells in the aPV, aberrant 
SS-positive axons, and abnormal SS-positive expression in the PL of Hes1 null mice. 
The alterations in peptide content, and axon pathfinding to and termination in the 
pituitaries of Hes1 null mice indicate that Notch signaling facilitates the formation of AVP 
and SS neurons, guidance of hypothalamic axons to the pituitary, and neuropeptide 
processing.   
MATERIALS AND METHODS 
Mice  
Hes1 mutant mice were previously generated by replacing the first 3 exons with a 
neomycin-resistance cassette (Ishibashi, et al. 1994). Breeding colonies were generated 
at the University of Illinois at Urbana-Champaign (UIUC) and maintained on a mixed 
genetic background of C57B1/6J and CD1 mice.  All animal procedures were approved 
by the UIUC Institutional Animal Care and Use Committee.  Heterozygous males and 
females were mated to generate mixed genotype litters, which were genotyped as 
previously described (Jensen, et al. 2000). Embryos were collected at e10.5, e11.5, 
e16.5 and e18.5, and either prepared for immunohistochemistry or peptide extraction at 
e18.5.    
Immunohistochemistry  
After collection, embryos were fixed in formaldehyde, embedded in paraffin and 
processed for immunohistochemistry as previously described (Monahan, Rybak, 
Raetzman. 2009). Primary antibodies were as follows: rabbit anti-arginine vasopressin 
(Abcam, Cambridge, MA USA 1:500; Fitzgerald Industries, Acton, MA, USA 1:500), 
rabbit anti-somatostatin-28 antibodies (Bachem, Torrance, CA, USA 1:500; Millipore, 
Billerica, MA, USA 1:100), rabbit anti-phosphohistone H3 (PH3) (Millipore, 1:300). 
Species specific secondary antibodies were purchased from Jackson Immunoresearch 
(West Grove, PA, USA). Nickel (II) sulfate 3,3-diaminobenzidine (NiDAB) 
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immunohistochemistry, adapted from (Kramer, et al. 2005) was performed on 
parasagittal sections embedded at a 30° horizontal plane.  Subsequent to primary and 
secondary antibody incubation, a Vectastain kit (Vector Laboratories, Burlingame, CA, 
USA) diluted in PBS was used.  Slides were then equilibrated in 0.175M sodium acetate.  
Next, NiDAB solution (2.5% nickel II sulfate, 2% DAB, 0.02% H202 in sodium acetate) 
was applied to the slides for 20–30 minutes at room temperature.  Slides were then 
washed in 0.175M sodium acetate 2 times for 5 minutes and PBS 2 times for 5 minutes.  
Finally, slides were counterstained with methyl green, dehydrated and mounted with 
Permount (Fisher).  Samples were visualized at a 100×, 200× and 400× magnification 
using a Leica DM 2560 microscope.  Images were taken using Q Capture Pro software 
(QImaging, Surrey, BC, Canada) and processed with Adobe Photoshop, version 11.0.2 
(Adobe Systems Incorporated, San Jose, CA, USA).   
PH3-positive and AVP-positive cell quantification  
Midsagittal sections of the VD taken from Hes1 null embryos and littermate controls at 
e10.5 and e11.5 were immunostained with PH3 and DAPI as described. Sections from 
the mid-PVN and mid-SON of Hes1 null embryos and littermate controls at e16.5 were 
immunostained with AVP as described.  Images were taken at 200× magnification.  The 
number of solid PH3-positive cells in the VD were counted and divided by the total 
number of DAPI-positive cells in the VD to obtain the proportion of PH3-positive cells in 
the VD. The numbers of AVP-positive cells were counted in the mid-PVN and mid-SON. 
For PH3 and AVP cell counts, 4 sections per animal were analyzed and the average 
proportion of PH3-positive or AVP-positive cells was compared between three Hes1 null 
embryos and three littermate controls.  These values were tested for statistical 
significance using a Student’s t test (SAS 9.1 software; SAS Institute, Cary, NC, USA).   
Quantitative real time-PCR 
Whole brains were dissected at e16.5 and snap frozen in ethanol.  RNA was extracted 
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with Trizol (Invitrogen, Carlsbad, CA, USA).  Reverse transcription was performed to 
create cDNA from 0.5g of isolated mRNA template. qRT-PCR was performed using 
cDNA with primers for AVP, GAD1 and GAPDH.  The primer sequences are as follows: 
AVP forward 5’ CTC TCC GCT TGT TTC CTG AG 3’, AVP reverse 5’ CTC TTG GGC 
AGT TCT GGA AG 3’, GAD1 forward 5’ CTC CAA GGA TGC AAC CAG AT 3’, GAD1 
reverse 5’ CTG GAA GAG GTA GCC TGC AC 3’, GAPDH forward 5’ GGT GAG GCC 
GGT GCT GAG TAT G 3’, GAPDH reverse 5’ GAC CCG TTT GGC TCC ACC CTT C 3’. 
Samples were run and analyzed on Bio-Rad iCycler IQ (Bio-Rad Laboratories, Hercules, 
CA, USA).  The PCR conditions for all primer sets used were 95 C for 20 sec, 55 C for 
30 sec, and 72 C for 30 sec (40 cycles).  AVP and GAD1 cycle threshold was 
normalized to GAPDH cycle threshold and data was analyzed with the ΔCT method.   
Peptide extraction for mass spectrometry  
Pituitaries from embryos were isolated and peptides were extracted from the isolated 
pituitaries using acidified acetone. Pituitaries from were pooled and analyzed with liquid 
chromatography mass spectrometry (LC-MS) to determine the sequences of the major 
peptides. Individual pituitaries from two control and two Hes1 null mice were analyzed 
with direct matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) MS 
(see Supplemental methods).   
Peptide identifications via liquid chromatography–mass spectrometry 
Chromatographic separation of the extracted peptides was achieved using a CapLC 
system (Micromass, UK). The samples were loaded onto a trap column and eluted onto 
a reversed phase capillary column. For LC-MALDI-TOF/TOF-MS analysis, 
chromatographic separation was performed and chromatographic elutant spotted onto a 
MALDI plate. A Bruker Ultraflex II TOF/TOF instrument was used to analyze each 
sample.  
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RESULTS 
Loss of Hes1 does not alter progenitor proliferation in the early developing ventral 
diencephalon 
 Generation and proliferation of neuronal precursors that populate the endocrine 
SON and PVN occurs between e10.5 and e12.5 in mouse (Karim, Sloper. 1980). We 
hypothesize that Hes1 is needed to control proliferation of VD progenitors during early 
embryonic development. To assess whether proliferating VD progenitors are completing 
mitotic division, we utilized PH3 as a marker of the M and late G2 phase of the cell cycle.  
In controls, proliferating PH3-positive cells are detected in the VD of e10.5 animals (Fig. 
2.1A, arrows). In comparison, Hes1 null animals appear to have similar expression 
patterns, with cells in mitosis lining the ventricular zone (Fig. 2.1B).  Cell count analysis 
of VD progenitors reveals no significant changes in proliferation between control (mean 
percent 16.8+1.6; n=3) and Hes1 null animals (mean percent 17.6+0.8; n=3).  By e11.5, 
controls show VD expansion, with cells in mitosis remaining in the ventricular zone (Fig. 
2.1C).  Hes1 null VD proliferation again mirrors that of controls (Fig. 2.1D) and cell count 
analysis reveal no significant change in the numbers of cells in mitosis between control 
(mean percent 15.2+0.8; n=3) and Hes1 null (mean percent 13.9+1.2; n=3) animals.  
These data taken together indicate that loss of Hes1 does not significantly alter VD 
progenitor proliferation, specifically with regard to the population of cells in mitosis, and 
that Hes1 alone may not contribute to expansion of progenitors at early stages of VD 
development. 
During pituitary development, loss of Hes1 can induce cell death in progenitors 
that have prematurely exited the cell cycle (Raetzman, Cai, Camper. 2007). We 
hypothesize that loss of Hes1 in the developing VD may also cause loss of progenitors 
through cell death.  In order to assess cell death in the VD, we utilized TUNEL 
immunohistochemistry to label cell populations undergoing cell death during early 
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development.  At e10.5, controls (Fig. 2.1E, arrows) and Hes1 null (Fig. 2.1F, arrows) 
animals reveal few TUNEL positive cells in the developing VD. At e11.5, few if any cells 
in the VD have positive staining in either the controls (Fig. 2.1G) or Hes1 null (Fig. 2.1H) 
animals.  This lack of TUNEL-positive cells indicates that loss of Hes1 does not induce 
cell death in the growing VD. 
Hes1 is necessary for proper formation of AVP neurons within the SON and PVN   
 Expression studies have discovered that AVP neurons within the PVN and SON 
are formed by e14.5 in the mouse (Altman, Bayer. 1978; Altman, Bayer. 1979; Bayer, 
Altman. 1987). However, the precise mechanisms underlying cell placement and axon 
migration of neuroendocrine hypothalamic neurons remain elusive. We hypothesize that 
the Notch signaling is important for proper formation and migration of hypothalamic 
neurons that project to the pituitary.   
 In both Hes1 null and control mice at e16.5, the SON is formed in a lateral 
cluster superior to the optic nerve, and AVP-positive cells migrating to the SON can be 
visualized (Fig. 2.2).  In control animals, at the level of the PL, there are no AVP-positive 
cells, as this region is posterior to the SON (Fig. 2.2A, 2.2A’).  However, Hes1 null 
animals display a lateral cluster as well as a ventromedial cluster of AVP positive cells at 
the level of the PL (2.2B, 2.2B’), suggesting that SON boundaries reach more posteriorly 
in Hes1 null animals.   At the more anterior level of the median eminence (ME), control 
animals show AVP-positive cell bodies superior to the optic nerve, as well as a 
ventromedial cluster, medial to the SON (Fig. 2.2C, 2.2C’).  In contrast, Hes1 null 
animals show a more dispersed SON boundary, as well as a medial cluster of cells, 
which span more dorsally compared to control AVP-positive cells (Fig. 2.2D, 2.2D’).  In 
more anterior sections, the number of AVP neurons in the SON is comparable between 
Hes1 null and control animals (data not shown).  There is no significant difference in 
relative levels of AVP mRNA in whole brains at e16.5 between control and Hes1 null 
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animals (data not shown), indicating that loss of Hes1 alters cell body position but not 
overall AVP neuron number within the PVN and SON.  
 GABAergic neurons have been shown to surround the PVN during development 
in order to establish the boundaries of AVP neurons within this region (McClellan, 
Stratton, Tobet. 2010). We therefore examined the expression of GAD67, which 
catalyzes the conversion of glutamate to GABA and marks GABAergic neurons, to 
assess if loss of Hes1 affects the expression of GABAergic neurons surrounding the 
developing SON and PVN at e16.5.  In normal animals, GAD67 is expressed 
surrounding the SON, such that GAD67 immuno-negative regions delineate the SON 
region (Fig. 2.2E).  In contrast, Hes1 null animals display GAD67 expression within the 
SON and appear to have increased GAD67-immunopositive neurons at the level of the 
SON (Fig. 2.2F).   
 The boundary of AVP neurons within the PVN is also affected in Hes1 null 
animals at e16.5.   AVP-positive cells form a distinct trapezoid shape in control animals 
at e16.5 (Fig. 2.2G), but AVP expression is unrestricted around the third ventricle of 
Hes1 null littermates (Fig. 2.2I).  Hes1 littermate controls show GAD67 immunoreactivity 
around the PVN, but little expression within this region (Fig. 2.2H).  In contrast, GAD67 
immunoreactivity appears increased at the level of the PVN in Hes1 null animals, and is 
present within the PVN region (Fig. 2.2J). However, there is no significant difference in 
relative levels of GAD mRNA in whole brains at e16.5 between control and Hes1 null 
animals (data not shown).  These data indicate that disruption in selective GABA 
signaling surrounding the SON and PVN may affect the boundary of AVP neuron 
expression within this region.  
 To establish the AVP-positive cell placement within the PVN and SON once cell 
migration and nuclei formation is complete, we compared these regions in Hes1 null and 
control animals at e18.5.  There is continued misplacement of AVP-positive cell bodies 
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within the PVN and SON of Hes1 null embryos (Fig. 2.3).  AVP-positive cells within the 
PVN are located in a distinct pattern on either side of the third ventricle in control 
animals (Fig. 2.3A), but are more diffusely expressed in Hes1 null mice (Fig. 2.3B). 
Additionally, while the SON of control animals consists of a tight cluster of AVP-positive 
cell bodies superior to the optic nerve (Fig. 2.3C), Hes1 null mice show AVP-positive 
cells following the border of the mesenchyme (Fig. 2.3D), consistent with the scattered 
expression of medial AVP-positive cells found near the SON at e16.5 (Fig. 2.3D). There 
is no significant difference in the total number of AVP positive cells in the mid PVN and 
SON between control (PVN, 30.6±0.8; SON, 29.8±0.5) and Hes1 null animals (PVN, 
31.2±0.5; SON, 30.7±0.3) at e18.5.  
Hes1 is necessary for formation of the PL 
 Given the alterations in placement of AVP-positive cells within the SON and 
PVN, we examined whether the axons of these neurons reach their target, the PL.  AVP 
axons originating from the PVN project laterally to the SON and then return to the center 
of the head to travel through the median eminence (ME) and reach the PL at e18.5. 
Using immunohistochemistry techniques to analyze e18.5 pituitaries, we found that 
control animals show robust expression of AVP-positive terminals within the PL (Fig. 
2.4A).  In contrast, Hes1 null mice show a decrease in AVP-positive axon terminals 
within the hypomorphic PL, indicating some but not all AVP-positive axons reach their 
target in these mice (Fig. 2.4B). We then examined whether the AVP axons of Hes1 null 
mice reach their first target, the ME, before they terminate within the PL.  We found 
robust AVP expression within the ME of control animals (Fig. 2.4C).  However, Hes1 null 
animals have a decrease in AVP axons within the ME and AVP-positive axons project 
laterally in the same plane of section, anterior to the PL (Fig. 2.4D). The aberrant cluster 
of AVP-positive projections could account for the reduction of AVP-positive terminal 
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axons within the PL in Hes1 null mice, as axons appear to be projecting elsewhere, 
lateral to the ME.  
Altered axonal trajectory of AVP neurons in Hes1 null mice   
 In order to further visualize the axons travelling from the ME to the PL at e18.5 in 
Hes1 null mice, we analyzed sections from heads embedded sagittally 30° from the 
horizontal plane (Fig. 2.5).  In control animals, AVP-positive cells within the SON are 
visualized at the level of the AL (Fig. 2.5A).  In contrast, the same level of the AL within 
the Hes1 null embryos contains AVP axons traveling through the ME as well as AVP-
positive cells within the SON (Fig. 2.5B), indicating that the ME is misplaced in the head 
of Hes1 null animals.  In a more posterior section, both the AL and IL are visualized in 
control animals, as well as a cluster of AVP-positive cell bodies, likely the SON (Fig. 
2.5C).  At the same level containing the AL and IL, Hes1 null animals also display AVP-
positive axons traveling through the ME and AVP-positive cell bodies and axon terminals 
in a lateral cluster (Fig. 2.5D).  Posteriorly, the AVP axons traveling through the ME to 
reach the PL can be visualized in control animals (Fig. 2.5E).  However, axons traveling 
through the ME are located more anteriorly in Hes1 null animals, in a section containing 
the AL and IL.  Therefore, in a more posterior section containing the PL, Hes1 null 
animals display no ME or traveling AVP axons, and a cluster of AVP-positive cells and 
axon terminals located in the same region as the SON in more anterior sections (Fig. 
2.5F, 2.5F’).  These findings could explain the reduction in the amount of AVP-positive 
axon terminals within the PL of Hes1 null animals, as AVP axons traveling through the 
ME are apparent far more anteriorly than control animals and are likely misguided as a 
result. Regardless, Hes1 is clearly necessary for proper axon migration of AVP neurons 
to their targets, the ME and the PL.   These findings, compiled with data from AVP cell 
body placement, are summarized in Fig. 2.6.   
Hes1 affects peptide content within the pituitary  
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Given the abnormal projection of AVP axons and the reduction of AVP 
expression within the PL, we hypothesized that Hes1 null pituitaries may have altered 
peptide content compared to controls.  Previous studies have shown that Hes1 is 
important for proper differentiation of peptide- producing cell types within the AL and IL; 
specifically, Hes1 null mice display a loss of pro-opiomelanocortin (POMC) cells within 
the IL, and a reduction in proteins produced from POMC cleavage, such as melanocyte-
stimulating hormone (αMSH) (Raetzman, Cai, Camper. 2007). Reduction in αMSH levels 
is coincident with reduced prohormone convertase 2 (PC2) expression in the IL of Hes1 
null mice, an enzyme necessary to cleave POMC into MSH (Raetzman, Cai, Camper. 
2007). We used MALDI-MS to analyze peptide content in Hes1 null and control 
pituitaries at e18.5. Interestingly, POMC [108-120], [103-120], [141-162] and αMSH were 
detected only in control animals (Fig. 2.7, Table 1). The fact that POMC and αMSH were 
not detected in Hes1 null pituitaries correlates with previous results reporting differences 
in melanotrope specification within Hes1 null pituitaries, and the reduction in PC2 within 
the intermediate lobe of Hes1 null animals at e18.5 (Raetzman, Cai, Camper. 2007).  
 Additionally, ProAVP/AVP-related peptides were detected in both Hes1 null and 
littermate controls, and a C-terminus form of ProAVP [151-168] was found only in Hes1 
null animals (Fig. 2.7, Table 1), which may be related to levels of detection or 
physiological differences in processing. Surprisingly, a form of SS (m/z 972.82) was 
detected in Hes1 null animals only (Fig. 2.7, Table 1). Although SS is released into the 
ME to act on the AL through the portal vasculature, it should not be detectable in the 
pituitary extracts at this age. Overall, these data suggest that Notch signaling, directly or 
indirectly, may impact peptide processing, as Hes1 null pituitaries display a different 
peptidomic profile compared to controls. 
Hes1 loss leads to reduction of SS neurons in the aPV, and aberrant axonal tracts 
to and expression within the PL  
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 Based on the MS observations of alterations in SS peptide content within the 
pituitary of Hes1 null animals at e18.5, we investigated SS protein expression in these 
animals using immunohistochemistry.  In the aPV of control animals, SS-positive 
neurons are found lateral to the third ventricle (Fig. 2.8A), and the numbers of SS-
positive neurons appear to be reduced in Hes1 null animals (Fig. 2.8B). Additionally, we 
found alterations in SS-positive axon projections, which normally project from the aPV to 
the median eminence.  At e18.5, control animals show no expression of SS-positive 
axons lateral to the ME (Fig. 2.8C), while Hes1 null mice display abnormal SS-positive 
axonal tracts in this region (Fig. 2.8D).  Abnormal SS-positive tracts were also observed 
along the mesenchyme border immediately dorsal to the PL at e18.5, and were not 
localized to mesenchymal or blood cells (data not shown).  Additionally, SS cell bodies 
were aberrantly found in the PL of Hes1 null pituitaries (1.75 cells/pituitary ±0.25, n=4, 
Fig. 2.8F), compared to WT mice (0 cells/pituitary n=4; Fig. 2.8E). These alterations in 
SS axon pathfinding and termination, together with the AVP data described, indicate that 
Hes1 may play a role in the guidance of hypothalamic axons to the pituitary.   
DISCUSSION  
 The principal role of Notch signaling during cortical development is to maintain 
neural progenitor identity and suppress neuronal differentiation (Schuurmans, Guillemot. 
2002). Loss of the Notch effectors Hes1 and Hes3 causes premature neuron formation 
in the mid/hind brain and subsequent loss of mid/hind brain structures (Hirata, et al. 
2001). Within the developing endocrine pituitary AL, loss of Hes1 causes a reduction in 
cell proliferation and decreased numbers of hormone-producing cells (Raetzman, Cai, 
Camper. 2007). Based on this data and the reduction in size of the PL within Hes1 null 
animals, we would have expected that Hes1 null mice would display premature 
differentiation of neuronal precursors, leading to a reduction in VD neuronal number. 
Consequently, we would have also expected decreased numbers of differentiated, AVP-
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positive neurons within the hypothalamic PVN/SON regions.  Instead our results indicate 
that Hes1 alone does not affect proliferation within the developing VD, or formation and 
specification of AVP neurons within the PVN and SON.  It is likely that other factors in 
the Notch signaling pathway, expressed in the same regions as Hes1, such as Hey1 
(Raetzman, et al. 2006) or Hes5 (Kita, et al. 2007), may be compensating for the loss of 
Hes1 in these animals.   It is also possible that earlier effects on proliferation and cell 
death escaped our detection, as our studies began analysis at e10.5, when the 
primordial posterior pituitary is already reduced in size.   
 Given the reduced size of the PL found in Hes1 null mutants, our studies 
focused on the specification, placement and projection of AVP neurons, which terminate 
in the PL. Our studies indicate that Hes1 is not necessary to form the appropriate 
number of AVP neurons.  However, we found that the number of SS-positive neurons 
within the aPV appears reduced in Hes1 null mice.  These data indicate that Hes1 may 
play a distinct role in the differentiation or placement of SS neurons in the aPV. 
Importantly, SS neurons require expression of Sim2 for proper differentiation, while AVP 
neurons do not (Goshu, et al. 2004). Within the developing spinal cord, the Notch 
signaling receptor Notch1 regulates the specification of certain lineages of interneurons.  
Loss of Notch1 results in overproduction of V2 neurons at the expense of motor neuron 
formation due to specific regulation of Lhx3+ cells (Yang, et al. 2006).  Therefore, it is 
possible that Hes1 may regulate transcription factors required for specific cell lineages 
and not others, allowing for the precision and specificity of normal neuronal 
differentiation.  Additionally, Notch signaling may be acting through Hes1 in a specific 
temporal context, such that differentiation signaling for AVP neurons acts at a different 
developmental time compared to differentiation of SS neurons, affecting SS but not AVP 
neuron number.  Though not addressed in our study, it is possible that loss of Hes1 
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affects the formation and placement of OT neurons, which also terminate in the PL and 
originate from the PVN and SON.    
Once AVP and SS neurons are born and differentiated, they migrate to the 
appropriate hypothalamic nuclei to exert their function.  Our results indicate a novel role 
for Hes1 in migration of AVP cell bodies within the PVN and SON.  Although Hes1 may 
be necessary intrinsically in AVP neurons to allow them to migrate appropriately, it is 
also likely that loss of Hes1 results in changes in the surrounding environment, which 
subsequently affects AVP cell body placement.  For instance, we found that GABAergic 
neurons were randomly distributed within the SON and PVN in Hes1 null mice compared 
to controls. It is possible that Hes1 is required to limit the extent of GABAergic 
differentiation in the developing HP because blocking Hes1 in human neural stem cells 
initiates GABAergic differentiation through induction of cyclin-dependent kinase inhibitor 
p21 (Kabos, Kabosova, Neuman. 2002). GABAergic neurons have been shown to 
surround the PVN during development in order to establish the boundaries of AVP 
neurons within this region (McClellan, Stratton, Tobet. 2010). It is possible that aberrant 
expression of GABAergic neurons within the developing PVN and SON affects 
delineation of PVN and SON boundaries, and contributes to the misplacement of AVP 
neurons in Hes1 null mice.   
In normal animals, once AVP neurons reach their nuclei, they begin to extend 
their axons to their targets.  Specifically, AVP neurons in the PVN travel ventrally and 
laterally to the SON and then all axons project back to the midline for entry into the ME 
and PL. Previous studies have implicated Notch signaling in axonal targeting within the 
cerebral cortex and hippocampus in conjunction with the extracellular matrix molecule 
Reelin (Alcantara, et al. 1998; Sibbe, et al. 2009). Reelin-deficient mice have reduced 
levels of cleaved NICD, and loss of Notch signaling in developing neurons results in 
faulty migration.  Furthermore, overexpression of NICD mitigates cortical neuronal 
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migration defects associated with Reelin null mice (Hashimoto-Torii, et al. 2008). Reelin 
mRNA is also expressed in the primordial PVN, SON and aPV during embryonic 
development (Alcantara, et al. 1998), although its relationship with members of the 
Notch signaling pathway, and Hes1 in particular, during hypothalamic development is 
unclear. It is possible that Hes1 may interact with Reelin within the developing endocrine 
hypothalamus to guide axons to their targets, the ME and pituitary.  
  In our study, the global loss of Hes1 may affect the developmental environment, 
such that normal guidance cues are dysregulated and axons are unable to navigate 
normally.  In Hes1 null animals, the ME is clearly misplaced within the head, which may 
contribute to the aberrant cluster of AVP axons and the reduced number of AVP axons 
within the PL.  The trophic components in and around ME during embryonic 
development are not well characterized, but support cells within the ME, called 
tanycytes, modulate hypothalamic neurons that travel through it in the mature HP 
(Givalois, et al. 2004; Prevot, et al. 2007; Prevot, et al. 2010). There is some evidence 
that hypothalamic gonadotropin-releasing hormone (GnRH) axons use cues from their 
target, the ME, for successful navigation (Rogers, Silverman, Gibson. 1997), and 
tanycytes may mediate these cues.  Hes1 null animals display premature differentiation 
and eventual depletion of radial glial cells (Hatakeyama, et al. 2004), which establish a 
structural framework to facilitate and direct axonal migration (Metin, et al. 2008).  It is 
possible that loss of Hes1 affects the proper development of support cells such as 
tanycytes in the ME, contributing to dysregulated axon guidance.  Additionally, loss of 
Hes1 may affect proper formation of pituicytes, the glial cell population within the PL, 
which could contribute to the misguided axon and hypoplastic pituitary phenotype.   
 Perhaps the most vital contributions to the identity of a hypothalamic neuron are 
the peptides that it synthesizes and releases.  Our data have uncovered a novel role for 
Notch signaling in the peptide content of hypothalamic neurons.  Peptide processing 
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occurs within the cell body of hypothalamic neurons, with peptides transported through 
the axons and released through axon terminals in the ME or PL. Our results indicate that 
Hes1 may play a role in peptide processing, as Hes1 null pituitaries display different 
peptidomic profiles compared to controls, including alterations in MSH, AVP and SS 
peptide content.  
There is precedence for other signaling pathways crucial for early embryonic 
development affecting neuropeptide processing. Homozygous Fgf8 hypomorphic mice 
show deficiency in post-translational processing and cleavage of the OT prohormone 
found in OT neurons of the PVN and SON (Brooks, Chung, Tsai. 2010). Additionally, 
Fgf2 treatment has been shown to cause incomplete processing of GnRH neurons such 
that the prohormone is cleaved into intermediate peptide products extended at the C-
terminus (Wetsel, Hill, Ojeda. 1996).  Taken together with our data, it is possible that 
Hes1 may play a role not only in the migration and projection of hypothalamic neurons, 
but also in their functional delivery of neuropeptide to the pituitary.   
 A specific and well-regulated cellular environment is crucial during development 
in order to establish proper connections between the hypothalamus and pituitary.  Early 
in embryonic development the primordial hypothalamus and pituitary are in physical 
contact and require reciprocal signaling.  Given that Hes1 is required for proper 
formation of the pituitary (Raetzman, Cai, Camper. 2007), it is possible that Notch 
signaling is required when contacting oral ectoderm and neural ectoderm are actively 
differentiating. Specifically, guidance signals from the oral ectoderm, fated to become 
pituitary, may be necessary to guide hypothalamic axons later in development. Notch 
signaling could also be a necessary intrinsic signal within neural ectoderm, and acts to 
guide AVP and SS hypothalamic neurons.  
 Notch signaling within the developing oral and neural ectoderm could also affect 
other signaling cascades, such as the FGF and BMP pathways.  Although previous 
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studies have shown that loss of Hes1 does not affect Fgf10 mRNA expression 
(Raetzman, Cai, Camper. 2007), it is possible there are changes in levels of FGF 
protein.  Additionally, other morphogens released from the developing diencephalon and 
infundibulum, such as BMPs, may affect early PL formation. Future studies utilizing 
tissue-specific Notch knockout mice will clarify whether autonomous Notch signaling is 
required in the developing hypothalamus, pituitary, or both, for proper development and 
migration of hypothalamic neurons and their axons.   
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Fig. 2.1.  Loss of Hes1 does not alter progenitor proliferation or cell death in the 
early developing ventral diencephalon.  Midsagittal sections of mouse embryos at 
e10.5 and e11.5 were immunostained with phosphohistone H3 (PH3) to visualize 
proliferating progenitors in the developing ventral diencephalon (VD). At e10.5, PH3-
positive cells are detected in the ventricular zone of the VD in both controls (A, arrows) 
and Hes1 null (B, arrows) animals. At e11.5, like e10.5, proliferating progenitors are 
restricted to the ventricular zone in both control (C) and Hes1 null animals (D). Cell 
death was detected using TUNEL in e10.5 and e11.5 control and Hes1 null animals. At 
e10.5, few cells are undergoing cell death in the VD in control (E, arrows) or Hes1 null 
(F, arrows) animals. At e11.5 few if any dying cells can be visualized in the VD of both 
control (G, arrows) and Hes1 null (H, arrows) animals. Two sections from three 
individual embryos were examined for each genotype.  Scale bar indicates 50µm.  
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Fig. 2.2.  Loss of Hes1 causes increased and aberrant GABAergic neuron 
expression and faulty placement of AVP neurons in the SON and PVN at e16.5.  A. 
Represents area within red box of A’ and shows no immunohistochemical detection of 
arginine vasopressin (AVP) cell bodies in coronal sections at the level of the PL in 
controls.   B. Represents area within red box of B’ and shows that at the same level of 
the PL, Hes1 null mice show AVP-positive cells in a medial cluster as well as a few 
scattered cells laterally.  C. Represents area within the red box of C’ at the level of the 
medial median eminence (ME), 198µm anterior to the PL, and shows medial AVP-
positive cell bodies in a ventromedial cluster as well as a cluster superior to the optic 
nerve in the supraoptic nucleus (SON) in controls.  D. Represents area within the red 
box of D’ and shows more dorsal AVP-positive cells at the medial median eminence 
(ME), 126µm anterior to the PL in Hes1 null animals. Control animals show GAD67 
immunoreactivity around the region of the SON at all levels, but not within the SON (E, 
red box).  In contrast, Hes1 null animals display an increase of GAD67-positive cells in 
and around the SON (F, red box denotes SON). Control animals show AVP 
immunoreactivity in the paraventricular nucleus (PVN), forming a trapezoid pattern at the 
third ventricle (G), while Hes1 null animals have more diffuse AVP-positive cells in that 
region (I). GAD67-positive cells mostly surround the PVN in control animals (H), but are 
found within the PVN in Hes1 null mice. Fifty sections from 6 individual embryos were 
examined for each genotype.  Scale bar indicates 50µm.  
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Fig. 2.3.  Loss of Hes1 causes disruption of AVP cell body placement in the PVN 
and SON at e18.5.  Immunodetection of arginine vasopressin (AVP) cell bodies in 
coronal sections (red, co-labeled with nuclei stained with DAPI in blue) shows robust 
staining within the paraventricular nucleus (PVN; A, dotted box).  In contrast, AVP-
positive cells in Hes1 null animals extend outside this region (B, dotted box).  AVP-
positive neurons within the superior optic nucleus (SON) form a tight cluster in control 
embryos (C), while they sit in a linear and more diffuse pattern in the SON of Hes1 null 
animals (D). Forty sections from 4 individual embryos were examined for each genotype.  
Scale bar indicates 50µm. 
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Fig. 2.4.  Loss of Hes1 results in pituitary hypoplasia, reduction of AVP neurons in 
the posterior lobe, and AVP axon misguidance at e18.5.  Immunodetection of 
arginine vasopressin (AVP) axon terminals in coronal sections (red, nuclei stained with 
DAPI in blue) fill the posterior lobe (PL) of control animals (A), while AVP-positive axons 
are substantially reduced in the PL of Hes1 null animals (B).  AVP-positive axons are 
present in the median eminence (ME) of Hes1+/+ mice (C), but are reduced in Hes1 null 
animals and are present in an ectopic cluster lateral to the ME (D). Thirty sections from 4 
individual embryos were examined for each genotype.  Scale bar indicates 50µm. 
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Fig. 2.5. Loss of Hes1 causes misplacement of the median eminence and ectopic 
AVP axon termination at e18.5.  Parasagittal sections cut 30° to the horizontal plane 
(A, inset), show immunodetection of AVP neurons (yellow, nuclei stained in red) in a 
cluster superior to the optic nerve in the supraoptic nucleus (SON) at the level of the 
anterior lobe of the pituitary (AL; A, dotted box).  At the same level, Hes1 null animals 
show a smaller AL, AVP axons traveling through the median eminence (ME), as well a 
cluster of AVP neurons lateral to the ME (B, dotted box).  More posteriorly, AVP neurons 
are still present in the SON of control animals (C, dotted box).  In Hes1 null animals, 
AVP-positive neurons are present superior to the optic nerve in the SON (D, dotted box) 
and AVP axons can be detected traveling through the ME.  At the level of the posterior 
lobe (PL) in control animals, AVP-positive axons are visualized traveling through the ME 
to their target, the PL (E).  However, Hes1 null animals show only clusters of AVP axons 
at this level (F, dotted box), as well as AVP axons in a smaller PL. F’. Magnification of 
the axon processes in F.  Thirty sections from 3 individual embryos were examined for 
each genotype.  Scale bar indicates 50µm. 
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Fig. 2.6. Schematic representation of changes in AVP cell body placement and 
AVP axonal trajectory in Hes1 null mice.  Control animals show arginine vasopressin 
(AVP) positive cell bodies (blue circles) within the region of the paraventricular nucleus 
(PVN) and supraoptic nucleus (SON) and few AVP immunopositive cell bodies at the 
level of the median eminence dorsally (ME; A).  AVP axons (pink lines) travel from AVP 
cell bodies in the PVN to the SON and project medially though the ME to reach the 
posterior lobe (PL; A).  Hes1 null animals display AVP-positive cell bodies outside of the 
PVN and SON, as well as AVP positive cell bodies at the level of the ME and PL in a 
more ventral region compared to controls (B).  AVP axons travel from the PVN to the 
SON and are found ectopically at the level of the ME, which itself is aberrantly located 
closer to the PL in Hes1 null mice.  Fewer AVP axons terminate in the PL of Hes1 null 
animals, which is frequently smaller compared to controls (B). 
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Fig. 2.7.  Loss of Hes1 affects peptide content within the pituitary at e18.5. MALDI 
MS profile comparing relative intensities of peptides by mass/charge (m/z) detected in 
Hes1 null and control pituitaries using an acidified acetone extraction method.  
Somatostatin [92-100] and Pro-AVP [151-168] were found only in Hes1 null pituitaries.  
Control animals showed various forms of pro-opiomelanocortin (POMC) as well as 
detection of melanocyte stimulating hormone (MSH) not found in Hes1 null pituitaries.  
Both Hes1 null and control pituitaries contained cholecystokinin (CCK-8) and 
ProAVP/AVP.  
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Fig. 2.8.  Loss of Hes1 results in reduced SS-positive cells in the aPV, altered SS 
tracts and aberrant expression of SS in the posterior lobe at e18.5.  
Immunodetection of somatostatin (SS) cell bodies (red, co-labeled with nuclei stained 
with DAPI in blue) in the mid-aPV nucleus shows SS-positive cells surrounding the third 
ventricle (3V) in control animals (A), while Hes1 null animals show a decrease in SS-
positive cells in this region (B).  At the level of the medial median eminence (ME), there 
are no SS-positive tracts lateral to the ME in control animals (C), while Hes1 null animals 
show SS-positive axons along the ventral border of the brain (D).  Within the posterior 
lobe, control animals display no SS-positive cells in the posterior lobe (PL; 0 cells, n=4) 
or intermediate lobe (IL; E).   However, Hes1 null pituitaries show aberrant expression of 
SS-positive cells in the PL (arrow; 1.75 cells ±0.25, n=4) and immunoreactivity in the IL 
(F). Forty sections from 4 individual embryos were examined for each genotype.  Scale 
bar indicates 50µm. 
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Table 2.1.  Summary of peptides identified by MALDI-MS in Hes1 null and control animals at 
e18.5. 
  
Prohormone/Peptide  Sequence       m/z  Hes1+/+  Hes1-/- 
Unknown   858.89  X  X  
Somatostatin [92-100]  SNPAMAPRE  972.82   X  
ProAVP/AVP  C*YFQNC*PRGa  1084.90  X  X  
CCK-8  DY(PO4)MGWMDFa  1142.93 X  X  
ProAVP [151-168]  VQLAGTRESVDSAKPRVY  1976.85   X  
Unknown   1330.19   X  
POMC [108-129]  VWGDGSPEPSPREa  1411.59 X   
MSHα [124-136]  SYSMEHFRWGKPVa  1622.65 X   
POMC [103-120]  AEEEAVWGDGSPEPSPREa  1941.71 X    
POMC [205-222]  (Ac)YGGFMTSEKSQTPLVTLF  2047.84   X  
POMC [141-162]  RPVKVYPNVAENESAEAFPLEF  2505.78  X   
 53 
CHAPTER 3: PERSISTENT EXPRESSION OF ACTIVATED NOTCH IN THE DEVELOPING 
HYPOTHALAMUS AFFECTS SURVIVAL OF PITUITARY PROGENITORS AND ALTERS 
PITUITARY STRUCTURE 
ABSTRACT 
The anterior lobe (AL) and intermediate lobe (IL) of the pituitary are formed from the 
primordial structure Rathke’s pouch, while the posterior lobe (PL) of the pituitary arises from an 
envagination of the developing hypothalamus. As the pituitary develops, signals from the 
hypothalamus are necessary for pituitary induction and expansion. Little is known about the 
control of cues that regulate early embryonic signaling between the two structures. Ligands and 
receptors of the Notch signaling pathway are found in the hypothalamus and Rathke’s pouch. 
The downstream effector gene Hes1 is required for proper formation of the AL, IL and PL, 
however these effects could be due to the action of Hes1 in the hypothalamus, Rathke’s pouch 
or both. To determine the contribution of hypothalamic Notch signaling to pituitary 
organogenesis, we used mice with loss and gain of Notch function specifically within the 
developing hypothalamus in cells that express Nkx2.1. We demonstrate that loss of Notch 
signaling by conditional deletion of Rbpjκ in the hypothalamus does not affect expression of 
Hes1 within the posterior hypothalamus or expression of Hes5. In contrast, expression of 
activated Notch within the hypothalamus results in ectopic Hes5 expression and increased Hes1 
expression, which is sufficient to cause loss of IL and PL structures and disrupt postnatal 
pituitary expansion. These changes in pituitary structure are accompanied by reduced 
hypothalamic OTX2 and Fgf10 expression and changes in Shh boundaries, coincident with 
reduced LHX3 expression within the pituitary and decreased survival of pituitary progenitors. 
Analysis of Hes1 null mice, that also have aberrant PL formation and LHX3 expression, 
additionally reveals ectopic expression of Hes5 in the posterior hypothalamus. Taken together, 
our results indicate that Rbpjκ-dependent Notch signaling within the developing hypothalamus is 
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not necessary for pituitary development, but persistent Notch signaling and ectopic Hes5 
expression in hypothalamic progenitors affects pituitary induction and expansion.   
INTRODUCTION 
Rathke’s pouch (RP), the primordium of the anterior lobe (AL) and intermediate lobe (IL) 
of the pituitary, arises from a distinct region of oral ectoderm midline, which lies in contact with 
the adjacent hypothalamus. As development continues, the infundibulum (INF), a portion of the 
contacting hypothalamus, envaginates into RP to form the posterior lobe (PL) of the pituitary 
(Schwind, J.L. 1928; Kaufman, 1992). The notion that hypothalamic signaling influences 
pituitary development has been well characterized by tissue recombination studies 
demonstrating that the hypothalamus is critical for appropriate pituitary expansion (Ericson, et 
al. 1998; Norlin, Nordstrom, Edlund. 2000). However, molecular mechanisms within the 
hypothalamus that direct pituitary formation are not well understood.  
 Known signals exchanged between the developing pituitary and hypothalamus include 
factors such as SHH, BMP, FGF and Wnt proteins (Dale, et al. 1997; Manning, et al. 2006), 
derived from both the primordial endocrine hypothalamus (BMP4, FGF8, FGF10, Wnt5a, SHH), 
and the oral ectoderm (SHH, BMP2, Wnt4; Alatzoglou, Dattani. 2009; Zhao, et al. 2012). These 
signaling molecules initiate expression of genes within RP, such as Lhx3, Lhx4 and Isl1, which 
control the initial steps of pituitary organogenesis (Treier, Rosenfeld. 1996; Takuma, et al. 1998; 
Ericson, et al. 1998; Norlin, Nordstrom, Edlund. 2000; Rosenfeld, et al. 2000; Zhu, Gleiberman, 
Rosenfeld. 2007). Despite their importance in controlling pituitary organogenesis, there is limited 
information regarding the developmental pathways that regulate expression of hypothalamic 
morphogens such as BMP and FGF. One important transcription factor is Nkx2.1, which is 
expressed within the hypothalamus and restricted from RP (Lazzaro, et al. 1991). Nkx2.1 is 
required for FGF8 expression in the infundibulum (Takuma, et al. 1998) and targeted deletion of 
Nkx2.1 results in early developmental arrest of pituitary organogenesis just after RP formation 
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(Kimura, et al. 1996; Takuma, et al. 1998). These studies indicate that the Nkx2.1 expressing 
hypothalamic progenitors are necessary for pituitary development.      
Once RP is induced with assistance from hypothalamic cues, proopriomelanocortin 
(POMC)-positive corticotropes that produce adrenocorticotropic hormone (ACTH) are the first 
cells to differentiate within RP of mice at embryonic day 12.5 (e12.5). Corticotrope differentiation 
is followed by differentiation of thyroid stimulating hormone (TSH)-positive thyrotropes at e14.5, 
growth hormone (GH)-positive somatotropes at e15.5, prolactin (PRL)-positive lactotropes at 
e16.5, and finally follicle stimulating hormone (FSH) and luteinizing hormone (LH) expressing 
gonadotropes around e16.5 (Simmons, et al. 1990; Japon, Rubinstein, Low. 1994). 
Melanotropes, found only in the IL and detected by POMC expression, begin producing 
melanocyte stimulating hormone (MSH) at e16.5 (Davis, Mortensen, Camper. 2011).  
Members of the Notch signaling pathway are expressed in both the developing pituitary 
and hypothalamus (Raetzman, et al. 2004; Aujla et al., 2013, In press) and have shown to be 
important for RP development and hormone specification (Ward, et al. 2005; Raetzman, et al. 
2006; Vesper, Raetzman, Camper. 2006; Raetzman, Cai, Camper. 2007; Himes, Raetzman. 
2009; Monahan, Rybak, Raetzman. 2009). Notch receptors and ligands are transmembrane 
proteins that allow cell-to-cell signaling between adjacent cells. Canonical Notch ligand 
activation results in cleavage of the Notch intracellular domain (NICD), which then translocates 
to the nucleus and associates with the Rbpjκ/Mastermind (MAM) complex (Selkoe, Kopan. 
2003). The NICD/Rbpjκ/MAM complex then induces transcription of basic helix-loop-helix 
(bHLH) transcription factors, such as Hes and Hey genes (Iso, Kedes, Hamamori. 2003). 
However, studies have shown that through Notch-independent pathways, Hes genes can be 
expressed in the absence of Rbpjκ (Martinez Arias, Zecchini, Brennan. 2002; Brennan, 
Gardner. 2002). Additionally, Rbpjκ/MAM can form transcriptional complexes that function 
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independently of Notch signaling, including repression and activation of target genes (Johnson, 
Macdonald. 2011)   
 The Notch target Hes1 has been shown to be important for development of both the 
hypothalamus and pituitary  (Aujla et al., 2011; Raetzman et al., 2007; Kita et al., 2007; Chapter 
4). More specifically, global Hes1 loss results in ectopic expression of Hes5, decreased cell 
proliferation and increased cell death within pituitary progenitor cells, coincident with loss of 
LHX3 (Raetzman et al., 2007; Kita et al., 2007). Hes1 expression is also necessary for proper 
melanotrope specification within the pituitary, possibly by restricting the expression of the 
transcription factor PIT1 (Raetzman, Cai, Camper. 2007). Additional studies have also used a 
conditional deletion approach to define the role of Notch signaling specifically in pituitary 
progenitors. Pituitary specific loss of Rbpjκ results in hypopituitarism with absence of the 
somatotrope, thyrotrope and lactotrope lineages (Zhu, et al. 2006).  The phenotype observed by 
pituitary specific loss of Rbpjκ-dependent Notch signaling is less severe than loss of Hes1 in 
both the pituitary and hypothalamus, suggesting that Notch signaling within the hypothalamus or 
cross-talk between the hypothalamus and pituitary is important for pituitary development. 
However, although the role of Notch signaling during pituitary development and cell specification 
has been explored, relatively little is known regarding the role of Notch within the hypothalamus 
itself and how this may impact RP development.  
 To determine if Notch signaling within the developing hypothalamus influences 
pituitary formation, we analyzed pituitary development in mice with hypothalamic-specific loss 
and gain of Notch function.   We demonstrate that loss of Rbpjκ-dependent Notch signaling in 
the hypothalamus selectivity eliminates Hes1 from the anterior hypothalamus (Chapter 4). 
However, loss of Notch/Rbpjκ signaling does not eliminate Hes1 from the posterior 
hypothalamus and has no effect on Hes5 expression or pituitary formation.  In contrast, 
persistent activation of Notch within the hypothalamus is sufficient to cause loss of the IL and 
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PL, which are still absent at 8 postnatal weeks.  Additionally, we show that persistent 
hypothalamic Notch activation results in a reduction of OTX2 and Fgf10 expression within the 
infundibulum, coincident with a reduction in LXH3 expression and aberrant cell death in RP. 
Persistent Notch expression additionally affects the boundaries of Shh expression within the 
posterior hypothalamus. Interestingly, persistent Notch expression within the hypothalamus 
does not affect specification of AL hormone cells, but does influence shape of the developing 
pituitary, and pituitary size is significantly reduced at 8 postnatal weeks. Taken together, we 
demonstrate that persistent Notch expression affects structural formation of the PL, morphology 
and proper cell specification within the IL, but not hormonal cell specification within the 
developing AL. Additionally, our results indicate that ectopic expression of Hes5 resulting from 
either persistent Notch expression or Hes1 loss have significant consequences on pituitary 
development.  
MATERIALS AND METHODS 
Animals  
RosaNotchICD floxed mice (Murtaugh, et al. 2003) purchased from Jackson Laboratories (Bar 
Harbor, ME, USA) and Rbpjκ floxed mice (Dr. Tasuku Honjo,  (Han, et al. 2002) were bred to 
Nkx2.1-cre mice (Lazzaro, et al. 1991; Xu, Tam, Anderson. 2008) purchased from Jackson 
Laboratories. Hes1 mutant mice were previously generated by replacing the first 3 exons with a 
neomycin-resistance cassette (Ishibashi, et al. 1994; gift from Dr. Kageyama). Breeding 
colonies were generated at the University of Illinois at Urbana-Champaign (UIUC) and all animal 
procedures were approved by the UIUC Institutional Animal Care and Use Committee. 
Genotyping was performed as described previously (Lazzaro, et al. 1991; Han, et al. 2002; 
Murtaugh, et al. 2003). 
Histology, immunohistochemistry and in situ hybridization  
Mice were collected at e10.5, e16.5 and 8 weeks, and fixed in 3.7% formaldehyde 
solution (Fisher, Pittsburg, PA) in PBS. For paraffin embedding (e10.5 and e16.5), the samples 
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were dehydrated in a graded series of ethanol before being embedded in paraffin and sectioned 
coronally or sagittally at 6 µm and mounted onto charged slides. For frozen sectioning (8 
weeks), pituitaries were placed in 30% sucrose diluted in PBS overnight, embedded in OCT 
medium, snap frozen at −80°C and sectioned at 10 µm. A hematoxylin and eosin stain was 
used to observe cell morphology. To prepare paraffin slides for immunofluorescence, the slides 
were deparaffinized in xylene and rehydrated in ethanol and PBS followed by a 10 min boil in 10 
mM citric acid (pH 6) for slides incubated with anti- PH3, anti-SOX2, anti-LHX3, anti-PAX7, anti-
pERK, anti-OTX2 and anti-PIT1 antibody. The frozen slides were incubated at room 
temperature for 10 min, fixed in 3.7% formaldehyde for 10 min, rinsed in PBS, and put in hot 
citrate for 5 min. All slides were then incubated in normal donkey serum [5% (wt/vol)] diluted in 
immunohistochemistry block, which consists of PBS, BSA (3%), and Triton X-100 (0.5%), 
followed by overnight incubation at 4°C with a primary antibody diluted in immunohistochemistry 
block against the desired peptide: phospho-histone-H3 (1:500 Upstate Cell Signaling Solutions, 
Lake Placid, NY), SOX2 (1:500, Millipore, Billerica, MA), p-ERK 1/2 (1:300, Santa Cruz 
Biotechnology, Santa Cruz, CA), LHX3 (1:1000, C651.6DbHN Developmental Studies 
Hybridoma Bank, University of Iowa, Iowa City, IA), PAX7 (1:500, Developmental Studies 
Hybridoma Bank, University of Iowa, Iowa City, IA), POMC (1:300, Dako, Carpinteria, CA), PIT1 
(1:800; a gift from Dr. Simon Rhodes), OTX1/2 (1:500, Abcam, Cambridge, MA), LHβ (1:1500; 
National Hormone and Pituitary Program-NHPP), FSHβ (1:1800; NHPP), GH (1:1000; NHPP), 
TSHβ (1:1000; NHPP), and AVP (1:1000; Millipore). Cell death was determined by the TUNEL 
(Terminal deoxynucleotidyl Transferase Biotin-dUTP Nick End Labeling) method using the in 
situ cell death detection kit (Roche, Indianapolis IN) according to the manufacturer’s protocol. 
Donkey-derived mouse and rabbit secondary antibodies conjugated to biotin (Jackson 
ImmunoResearch; West Grove, PA) were diluted to 1:200 and incubated with sections for 1 h. 
Slides were then incubated with tertiary antibodies, streptavidin conjugated to either cy2 or cy3 
 59 
fluorophore (Jackson ImmunoResearch) for 1 h. All sides were counterstained with 4′,6-
diamidino-2-phenylindole dihydrochloride (DAPI; Molecular Probes, Grand Island, NY) at 1:1000 
(stock 1 mg/ml) and mounted using aqueous fluorescence mounting media.  
 For in situ hybridization (ISH) embryos were collected at e10.5 and embedded in paraffin 
as described for immunohistochemistry. Gene expression was detected with an antisense probe 
for Hes1 (Akazawa, et al. 1992), Hes5 (Akazawa, et al. 1992), Shh (gift from Dr. Douglas 
Epstein (Zhao, et al. 2012) and Fgf10 (Bellusci, et al. 1997) as previously described (Chapter 4). 
For all experiments described, 3-5 mice were analyzed per genotype. Samples were then 
visualized at 200× magnification using a DM 2560 microscope (Leica, Wetzlar, Germany) and 
images were obtained using Q Capture Pro software (QImaging, Surrey, British Columbia, 
Canada) and processed using Photoshop software (Adobe, San Jose, CA). 
Quantification of PH3 immunopositive and DAPI positive cells  
Sagittal sections throughout the primordial pituitary from control and NICD Tg mice at e10.5 
were immunostained with PH3 and DAPI as described. Images were taken at 100× 
magnification.  The number of total PH3-positive cells in RP were counted and divided by the 
total number of RP cells to obtain the proportion of PH3-positive cells. Total RP cell number was 
determined by counting DAPI-positive cells in four representative sections from each group and 
measuring pixel density within the counted region to determine the ratio of DAPI-positive cells 
per pixel. Pixel density of each section throughout the RP was then determined and multiplied 
by the ratio to obtain a total number of DAPI-positive cells for each section. For all cell counts, at 
least 10 sections per animal were analyzed and the average number of PH3-positive cells and 
DAPI-positive cells was compared between four NICD Tg embryos and four littermate controls 
in each group.  The average number of PH3-immunopositive cells over the average number of 
total cells for each animal was obtained and the mean and standard deviation of these averages 
was then calculated for each group. These values were tested for statistical significance using 
two-tailed t-tests in Microsoft Excel.  
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RESULTS 
Persistent expression of Notch and loss of Hes1 both result in ectopic Hes5 expression 
while loss of Rbpjκ  does not alter Hes1 or Hes5 within the posterior hypothalamus  
Notch signaling is active in the developing hypothalamus and pituitary and loss of 
function in both structures affects formation of the PL as well as differentiation and size of the IL 
and AL (Raetzman, et al. 2004; Ward, et al. 2005; Raetzman, et al. 2006; Vesper, Raetzman, 
Camper. 2006; Raetzman, Cai, Camper. 2007; Kita, et al. 2007; Monahan, Rybak, Raetzman. 
2009; Himes, Raetzman. 2009; Akimoto, et al. 2010). To determine the role of hypothalamic 
Rbpjκ-dependent Notch signaling in pituitary organogenesis, we employed conditional deletion 
of an essential cofactor of Notch receptors, Rbpjκ, in the developing hypothalamic progenitors 
(Han, et al. 2002). Rbpjκfl/fl mice (control) were bred to Nkx2.1-CRE mice (Lazzaro, et al. 1991; 
Xu, Tam, Anderson. 2008) to generate Rbpjκfl/fl Nkx2.1-CRE (Rbpjκ cKO) mice. To determine 
the effects of Notch overexpression within the developing hypothalamus, we utilized a tissue 
specific approach employing mice that express one copy of the constitutively active Notch1 
intracellular domain (NICD) within the hypothalamus (Murtaugh, et al. 2003). RosaNotchICD/+ mice 
(control) were bred to Nkx2.1-Cre mice, generating RosaNotchICD/+ Nkx2.1-Cre (NICD Tg) mice 
with persistent Notch activation in the Nkx2.1-positive hypothalamic progenitors by e9.5  
(Shimogori, et al. 2010; Ring, Zeltser. 2010; Ferri, et al. 2013).  
We examined expression of the Notch target Hes5 in order to examine how loss of 
Rbpjκ-dependent Notch signaling or persistent Notch activation would affect its expression at 
e10.5. We found that expression of Hes5 is normally restricted to the anterior hypothalamus 
(Fig. 3.1A), and that loss of Rbpjκ-dependent Notch signaling does not affect Hes5 expression 
within the anterior hypothalamus (Fig. 3.1B). Additionally, persistent expression of Notch results 
in ectopic expression of Hes5 within the posterior hypothalamus (Fig. 3.1C). We found that 
pituitary morphology in NICD Tg mice resembled that of Hes1 null mice so we examined Hes5 
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expression within Hes1 null mice and found ectopic Hes5 expression within the posterior 
hypothalamus and within RP (Fig. 3.1D).  We additionally examined expression of the Notch 
target Hes1, which is expressed throughout the posterior and anterior hypothalamus in control 
animals (Fig. 3.1E). Surprisingly, we found that Hes1 is still present within the posterior 
hypothalamus in Rbpjκ cKO mice, but is absent from the anterior hypothalamus (Fig. 3.1F). In 
contrast, persistent expression of Notch appears to increase Hes1 within the anterior and 
posterior hypothalamus (Fig. 3.1G).  
In summary, in control animals Hes5 is restricted to the anterior hypothalamus, while 
Hes1 is expressed in both regions (Fig. 3.1H). Loss of Rbpjκ-dependent Notch signaling results 
in loss of Hes1 only from the anterior hypothalamus and does not affect Hes5 expression, while 
both Hes1 null and NICD Tg have ectopic Hes5 expression throughout the posterior 
hypothalamus (Fig. 3.1I). Taken together, our results indicate that Hes genes may be regulated 
independently of Rbpjκ. Given that both Hes1 null mice and NICD Tg mice exhibit similar 
pituitary phenotypes, we further characterized how persistent Notch expression may affect RP 
formation.  
Persistent activation of hypothalamic Notch affects expression of patterning factors 
within the hypothalamus that communicate with Rathke’s pouch  
In control mice at e10.5, RP has separated from the oral ectoderm and the infundibulum 
(INF) has formed by evagination of the neural ectoderm (Fig 3.2A). Persistent activation of 
NICD within the developing hypothalamus allows formation of RP at e10.5, but the structure 
appears thinner and elongated with no apparent INF formation (Fig 3.2B). To investigate how 
persistent expression of Notch may affect expression of hypothalamic patterning genes crucial 
for proper pituitary formation, we examined the expression of Shh, OTX2 and Fgf10. Proper 
restriction of Shh is crucial to pituitary development (Zhao et al., 2012). We found that 
expression of Shh, which is restricted to the anterior hypothalamus (brackets) of control mice 
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(Fig. 3.2C), has altered expression boundaries in NICD Tg mice (brackets, Fig. 3.2D).  
To examine posterior hypothalamic patterning, we examined OTX2, which is present 
within the forming INF and posterior hypothalamic neuroepithelium (Mortensen et al., 2011). We 
found that OTX2 is expressed within the INF in control animals (brackets, Fig 3.2E), and is 
reduced in NICD Tg animals (brackets, Fig 3.2F). To further investigate INF differentiation and 
signaling, we examined Fgf10 mRNA, which is restricted to the INF of control animals (Fig 
3.2G).  Fgf10 expression is dramatically reduced in the hypothalamus of NICD Tg animals (Fig 
3.2H). Immunohistochemistry reveals uniform expression of phosophorylated-ERK1/2 (pERK) 
within RP, indicating activation of FGF signaling within the control pituitary (Powers, McLeskey, 
Wellstein. 2000; Corson, et al. 2003; Fig 3.2I). In contrast, NICD Tg animals display p-ERK 
immunoreactivity restricted to the rostral side of RP (Fig 3.2J), which potentially indicates 
restricted activation of FGF signaling within the pituitary from the hypothalamus. Overall, these 
data suggest that persistent expression of Notch signaling in the hypothalamus alters INF 
formation as well as OTX2, FGF, and Shh expression, which may affect signaling from the 
hypothalamus to the pituitary and alter pituitary development. 
NICD activation within the developing hypothalamus affects patterning and survival of 
pituitary progenitors  
 Cells within RP depend on FGF signaling from the posterior hypothalamus in order to 
induce intrinsic pituitary factors such as the LIM homeodomain transcription factor LHX3 
(Sheng, et al. 1996; Ericson, et al. 1998; Treier, et al. 1998; Norlin, Nordstrom, Edlund. 2000; 
Charles, et al. 2005). LHX3 is normally expressed throughout RP at e10.5 (Fig. 3.3A), but this 
expression is reduced in NICD Tg mice and restricted from the caudal side and dorsal tip of RP 
(Fig. 3.3B). An additional LIM homeodomain transcription factor, ISL1, is the first LIM protein to 
be expressed during pituitary development and becomes restricted to the ventral portion of the 
pouch by e10.5 (Zhu et al., 2007; Fig 3.3C). In contrast, ISL1 immunoreactive cells in NICD Tg 
pituitaries are not ventrally restricted and are also present in the dorsal region of the pouch (Fig 
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3.3D). Consistent with LHX3 expression at e10.5, visualization by TUNEL 
immunohistochemistry illustrates that there are no dying cells within Rathke’s pouch (Fig. 3.3E, 
(Raetzman, Cai, Camper. 2007; Monahan, Rybak, Raetzman. 2009), while NICD Tg mice have 
apoptotic cells in caudal side of RP where LHX3 expression is eliminated (Fig. 3.3F).  
 We examined proliferation of pituitary progenitors within RP by immunohistochemistry 
labeling phospho-histone H3 (PH3) in order to visualize cells undergoing mitosis. We found that 
NICD Tg animals (Fig 3.3H; 138.6±7.8, p=0.03) have significantly more DAPI-positive cells in 
the elongated RP compared to controls (Fig 3.3G; 96.3±9.8).  We then counted PH3-
immunopositive cells within RP to determine the average percent of PH3-immunopositive cells 
per total cells and found that NICD Tg pituitaries have a significantly lower percentage of 
proliferating cells (Fig 3.3H; 34.7±0.6%, p=0.03) compared to control pituitaries (Fig 3.3G; 
42.1±1.9%). Taken together, our results indicate that Notch overexpression within the 
hypothalamus results in disruption of proper pituitary induction, increased cell death and 
decreased proliferation.  
Persistent Notch activation in the developing hypothalamus affects pituitary morphology 
but not hormone specification  
 To determine if extrinsic Notch signaling from the hypothalamus affects pituitary 
hormone cell specification, we examined NICD Tg and control pituitaries at e16.5. 
Overexpression of NICD results in loss of a defined PL and IL (Fig. 3.4B anterior, Fig 3.4D 
posterior) compared to controls (Fig. 3.4A, anterior, Fig. 3.4C posterior), although a small cleft 
can be observed in NICD Tg mice (Fig. 3.4D, posterior, bracket). Hormone cells such as LH 
(Fig. 3.4E), GH (Fig. 3.4G), TSH (Fig. 3.4I) and POMC derivatives (Fig. 3.4K) are normally 
specified in AL by e16.5. NICD Tg animals display similar specification of these hormone cell 
types within the AL at the same age, though the structure itself is elongated into the forming 
sphenoid bone (Fig. 3.4F-3.4L).  Our results indicate that persistent Notch signaling within the 
hypothalamus does not affect terminal differentiation of pituitary hormone producing cells within 
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the AL, but does affect pituitary shape.  
NICD activation affects proper intermediate lobe formation and intermediate lobe 
hormone expression  
 In order to more carefully examine the dysmorphic region dorsal to the cleft in NICD Tg 
pituitaries at e16.5, we used immunohistochemistry to determine if this region contained 
intermediate lobe cell types. We found that SOX2, a marker of pituitary progenitors (Fauquier, et 
al. 2008), is present in cells within the IL of control animals at e16.5 (Fig. 3.5A), and is also 
present surrounding the cleft of NICD Tg pituitaries (Fig. 3.5B). We then examined PAX7, a 
marker of melantropes within the IL (Hosoyama, et al. 2010; Budry, et al. 2012), which is 
robustly expressed within the IL of control mice at e16.5 (Fig. 3.5C). NICD Tg pituitaries display 
no PAX7 immunopositive cells in the thin cell layer above the cleft (Fig. 3.5D) or within rest of 
the pituitary (data not shown), indicating that the IL may be not properly formed in these 
animals. Cells containing POMC derivatives melanocyte stimulating hormone (MSH) found in 
the IL, and adrenocorticotropic (ACTH) found in the AL, are both detected by POMC antibody in 
control animals at e16.5 (Fig 3.5K; Fig. 3.5E). In contrast, immunoreactive POMC cells are 
reduced in the region superior to the cleft of NICD Tg animals (Fig. 3.5F). Additionally, the 
morphology of POMC-immunopositive cells found in the region above the cleft in NICD Tg 
pituitaries resembles that of ACTH-positive cells found in the AL of controls, indicating that this 
region of cells may be an extension of AL surrounding the cleft.  
 In order to determine what cell types are present in the region superior to the cleft within 
NICD Tg animals, pituitaries were immunostained with an antibody to the homeodomain 
transcription factor PIT1.  Expression of PIT1, normally localized to the AL, is required for TSH, 
GH and prolactin (PRL) expression as well as proliferation of thyrotropes, somatotropes and 
lactotropes (Lin, et al. 1994; Ward, et al. 2006; Zhu, et al. 2006). In control animals, PIT1 is 
restricted from the IL (Fig. 3.5G), but PIT1 immunopositive cells are found in the region above 
the cleft in NICD Tg animals (Fig. 3.5H), indicating that there is no IL delineation. Interestingly, 
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GH expression, which requires PIT1, is restricted from both the IL in control animals (Fig. 3.5I), 
as well as the cells above the cleft in NICD Tg animals (Fig. 3.5J). These data show that the cell 
layer above the cleft found in NICD Tg pituitaries does not differentiate into the IL, though SOX2 
containing cells still form the boundary of the cleft. Taken together, these results indicate that 
persistent expression of Notch affects the boundary and formation of the IL and the AL within 
the developing pituitary.   
Persistent activation of NICD results in a smaller pituitary with no PL in adulthood  
 The pituitary substantially increases in size postnatally with clear delineation of AL, PL 
and IL in gross structure (Fig. 3.6A) and in histological sections throughout the pituitary (Fig. 
3.6B). NICD Tg animals have a severely affected pituitary shape and significantly reduced size 
(Fig. 3.6B, 3.6D). NICD Tg pituitaries are further set within the hypophyseal fossa of the 
sphenoid bone compared to controls (data not shown), and maintain the elongated shape 
observed in sagittal sections at e10.5 (Fig. 3.6B, Fig. 3.6D).  Throughout sections of the NICD 
Tg pituitary, no distinct IL or PL morphological regions are found. Additionally, a region of tissue 
500µm from the AL on a transverse section, yet still connected to the main AL tissue, was 
present (Fig. 3.6D).  
 At 8 postnatal weeks, the pituitary displays robust levels of GH within the AL in control 
(Fig. 3.6E) and NICD Tg (Fig. 3.6F) animals. TSH is also detected in both control (Fig. 3.6G) 
and NICD Tg pituitaries (Fig. 3.6H).  Both MSH within the IL and ACTH in the AL are detected 
with POMC antibody in control pituitaries (Fig. 3.6I), and POMC immunopositive cells are also 
found in NICD Tg pituitaries (Fig. 3.6J). Interestingly, while arginine vasopressin (AVP), staining 
axonal processes from hypothalamic magnocellular neurons, is appropriately restricted to the 
PL of control pituitaries (Fig. 3.6K), AVP-immunopositive processes are detected in the medial 
aspect of the AL in NICD Tg pituitaries (Fig. 3.6L).  The ectopic pituitary tissue shown in Fig. 
3.6D contained AL hormones such as GH, TSH, POMC, but did not contain AVP processes 
(data not shown). SOX2 is present in cells lining the cleft and in isolated AL cells of control 
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pituitaries at 8 weeks (Fig. 3.6M), as well as in the AL of NICD Tg mice (Fig. 3.6N). SOX2 
expression is maintained in the nucleus within cells in the control (Fig 3.7O, arrow), but in 
contrast cytoplasmic SOX2 immunoreactivity is observed in NICD Tg pituitaries (Fig 3.6P, 
arrow).  Taken together, these data suggest that although pituitary hormone expression is not 
affected by persistent hypothalamic NICD expression the pituitary morphology, pituitary size and  
SOX2 expression are profoundly disrupted.  
DISCUSSION 
 Notch signaling is present within the developing pituitary as well as hypothalamus and 
loss of the Notch effector gene Hes1 in both tissues results in hypopituitarism, coincident with a 
reduced PL  (Raetzman, et al. 2004; Raetzman, Cai, Camper. 2007; Aujla, et al. 2011). The 
hypopituitarism observed with global Hes1 loss could result from Notch signaling reduction in 
the hypothalamus, pituitary or both structures. In order to address if Notch signaling within the 
developing hypothalamus specifically is important for pituitary development, we utilized mice 
with hypothalamic specific loss of Notch/Rbpjκ signaling and compared them to Hes1 null mice. 
Our studies reveal that in Hes1 null mice, Hes5 is robustly and ectopically expressed within the 
posterior hypothalamus and that persistently expressing Notch1 in the anterior and posterior 
hypothalamus leads to a similar ectopic expression of Hes5 (Fig. 3.1). The pituitary phenotype 
observed in NICD Tg mice, including absent INF, increased apoptosis, reduced progenitor 
proliferation and reduced LHX3-immunopositive cells (Fig. 3.3) bears striking resemblance to 
Hes1 null pituitaries (Raetzman, Cai, Camper. 2007; Monahan, Rybak, Raetzman. 2009). 
Additionally, recent studies have shown that loss of the hypothalamic patterning factor Tbx3 
results in ectopic Hes5 expression, complete INF loss and pituitary malformation (Trowe et al., 
2013), supporting the assertion that restriction of Hes5 from the posterior hypothalamus is a 
crucial common factor that regulates INF formation and proper RP induction.  
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In contrast, Hes1 expression appears to be Rbpjκ-dependent within the anterior 
hypothalamus (Fig. 3.1) and Rbpjκ-independent within the posterior hypothalamus, as loss of 
Rbpjκ along the ventral midline selectively eliminated Hes1 from the anterior but not the 
posterior hypothalamus. Expression of Notch1 and Notch2 receptors are restricted to the 
anterior hypothalamus at e13.5 (Chapter 4), indicating that Hes1 expression within the posterior 
hypothalamus is acting through Rbpjκ-independent signaling. In fact, expression of Hes1 and 
other downstream Notch factors can be controlled by mediators of the BMP (Dahlqvist, et al. 
2003; Itoh, et al. 2004) and WNT/β-CATENIN (Axelrod, et al. 1996; Hayward, et al. 2005) 
pathways. These pathways are both present within the posterior hypothalamus and could be 
regulating Hes1 expression in an Rbpjκ-independent manner. Future studies should selectively 
eliminate Hes1 from the posterior hypothalamus to determine if Notch signaling within this 
region is necessary for pituitary development.  
An important finding from the current study is that posterior hypothalamic patterning 
relies on appropriate restriction of Notch signaling. We demonstrate that persistent Notch 
expression in Nkx2.1-positive cells beginning at e9.5  (Shimogori, et al. 2010; Ring, Zeltser. 
2010; Ferri, et al. 2013) affects the restriction of Shh expression (Fig. 3.2). Recent studies have 
shown that Shh restriction from the posterior hypothalamus is a critical factor in INF formation 
(Trowe et al., 2013). There is precedence for Notch and SHH interaction, as Notch and SHH 
pathways cooperate to form appropriate progenitor boundaries during neocortical development 
(Dave, et al. 2011). There is also evidence of direct cross-talk between SHH and the 
downstream Notch effector Hes1 in vitro (Ingram, et al. 2008).  Therefore, the lack of Shh 
restriction within the posterior hypothalamus observed in the current study could be due to direct 
interaction of persistently expressed Hes genes found in NICD Tg mice and SHH signaling 
factors (Fig. 3.1). Additionally, defects in Shh restriction lead to subsequent reduction in RP 
proliferation and increased apoptosis (Trowe et al., 2013), similar to phenotype observed in 
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NICD Tg mice. Taken together, these data suggest that persistent expression of Hes1 and Hes5 
prevents Shh restriction from the posterior hypothalamus and may contribute to the pituitary 
malformation observed. 
The developing INF represents an important hypothalamic boundary crucial to pituitary 
development. An important finding in our study is that persistent Notch expression results in 
absence of INF formation, with a corresponding reduction in OTX2 expression (Fig. 3.2). 
Notably, persistent Notch expression within the hypothalamus of NICD Tg mice results in 
persistent expression of the downstream Notch targets Hes1 and Hes5, and Hes genes have 
been shown to suppress expression of Otx2 by directly binding to the Otx2 enhancer EELPOT 
(Ogino, Fisher, Grainger. 2008; Muranishi, et al. 2011). The suppression of Otx2 by Hes genes 
in retinal progenitor cells maintains their progenitor fate and Hes genes are required to turn off 
to allow retinal progenitors to become photoreceptor precursors (Muranishi, et al. 2011). Taken 
together with our data showing that persistent Notch expression results in a lack of INF 
formation, it is possible that Hes genes must be turned off to allow for hypothalamic progenitors 
to adopt an INF cell fate. In fact, NICD Tg mice appear to have increased numbers of 
hypothalamic progenitors, whose cell fate as progenitors are maintained throughout embryonic 
development (Chapter 4).   
 The significant reduction in Fgf10 expression in NICD Tg mice offers further evidence 
that persistent Notch expression affects proper cell specification within the posterior 
hypothalamus. Notch interaction with FGF signaling pathways is not surprising. In both gastric 
and pancreatic development, FGF and Notch signaling work together to control progenitor 
behavior (Miralles, et al. 2006). During cardiac development, Notch is necessary for FGF 
expression (High, et al. 2009). Additionally, constitutively active Notch1 or Notch2 can prevent 
FGF release in vitro (Small, et al. 2003). Therefore, in the current study, persistent activation of 
NICD could lead to the decrease in Fgf10 observed in the posterior hypothalamus.  
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FGF8 and FGF10 expression within the posterior hypothalamus have been shown to be 
necessary for LHX3 expression and to maintain cellular proliferation within RP (Ohuchi, et al. 
2000; Kelberman, et al. 2009). Additionally, mice carrying a Fgf8 hypomorphic allele exhibit a 
smaller pituitary, including a reduced PL and altered IL and AL shape similar to those observed 
in NICD Tg mice (McCabe, et al. 2011). Furthermore, loss of Fgf10 results in apoptosis along 
the caudal aspect of RP (Ohuchi, et al. 2000). These data correspond with this dramatic 
reduction of Fgf10 found in the posterior hypothalamus of NICD Tg mice, and suggest that loss 
of FGF signaling activation within RP observed through reduced p-ERK immunoreactivity (Fig. 
3.2) could contribute to the cell death, loss of LHX3 and reduced proliferation found in RP (Fig. 
3.3).  
 Persistent expression of Notch within the hypothalamus additionally results in an 
apparent loss of proper IL structure (Fig. 3.5). The thin layer of cells superior to the cleft in NICD 
Tg animals is not PAX7-immunopositive and contains aberrant PIT1 positive cells normally 
found in the AL.  PAX7 labels IL progenitor populations, and is required for formation of 
hormone producing cells within the IL (Hosoyama, et al. 2010; Budry, et al. 2012). Therefore, 
persistent NICD expression appears to alter the formation of IL structure as well as IL cell 
population. When Hes1 is lost in both the hypothalamus and pituitary, IL structure appears 
thinner and PIT1 positive cells are also ectopically present within the IL. Additionally, IL 
melanotropes are not specified and IL cells adopt an aberrant somatotrope fate (Raetzman et 
al., 2007). Taken together, both NICD Tg and Hes1 null mice have disrupted IL structure and 
abnormal cell specification.   
 Both NICD Tg and Hes1 null mice additionally have disrupted PL structure  (Raetzman, 
et al. 2004; Raetzman, Cai, Camper. 2007; Aujla, et al. 2011) and there is precedence for loss 
of PL structure to disrupt IL cell fate. For example, loss of Lhx2 prevents proper INF formation 
and envagination into RP and the absence of PL structure results in subsequent malformation of 
IL structure as the pituitary develops (Zhao, et al. 2010). In the case of Lhx2 mutants, the 
 70 
absence of a PL does not allow RP to extend dorsally and therefore alters IL and AL 
morphology. Taken together with our data, this suggests that proper formation of the PL 
structure itself may be a crucial mediator of IL formation.  
Interestingly, NICD Tg mice examined at 8 postnatal weeks never develop an IL or PL, 
and show a significant reduction in AL size compared to controls (Fig. 3.6), indicating that there 
is little postnatal pituitary expansion. NICD Tg mice additionally show presence of cytoplasmic 
expression of SOX2, representing cells in later stages of progenitor development, but not yet 
differentiated into terminal cell fate (Chen, et al. 2009; Gremeaux, et al. 2012). Despite the 
reduction in pituitary size and increased cytoplasmic expression of SOX2, hormone cells in the 
AL appear to be specified properly, indicating that Notch signaling within the hypothalamus may 
not affect AL hormone specification, and that intrinsic pituitary factors are important for these 
factors after initial pituitary induction.  This would suggest that although the hypothalamic 
signals are not essential for pituitary cell differentiation, the disrupted hypothalamic milieu of the 
NICD Tg mice prevents signals necessary for additional postnatal pituitary growth. 
 Taken together, our results indicate that Rbpjκ-dependent Notch signaling within the 
developing hypothalamus is not necessary for pituitary development, but persistent Notch 
signaling in hypothalamic progenitors mimics the phenotype of Hes1 null mice and affects 
pituitary induction and expansion.  We show that persistent hypothalamic Notch activation 
disrupts hypothalamic patterning, coincident with decreased pituitary progenitors. This is likely 
due a combination of reduced hypothalamic FGF signaling as well as a lack of restricted SHH 
signaling from the posterior hypothalamus. Disruption of the temporal and spatial control of both 
FGF and SHH within the hypothalamus along the ventral midline is thought to be a causative 
factor of Septo-optic dysplasia and accompanying hypopituitarism (McCabe, et al. 2011; Zhao 
et al., 2012). Future studies should selectively eliminate Hes1 and Hes5 from the posterior 
hypothalamus to determine how Notch is interacting with these important pathways. 
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Figures 
 
 
 
Fig. 3.1. Loss of Rbpjκ  does not alter Hes1 or Hes5 expression while both persistent 
Notch activation and Hes1 loss results in ectopic Hes5 within the posterior 
hypothalamus. In situ hybridization performed on sagittal sections at e10.5 shows Hes5 
expression restricted within the anterior hypothalamus in control (A) and Rbpjκ cKO (B) mice. In 
contrast, NICD Tg mice (C) and Hes1 null mice (D) have ectopic Hes5 expression within the 
posterior hypothalamus. Additionally, Hes1 is expressed within the anterior and posterior 
hypothalamus in control mice (E), is absent from the anterior hypothalamus in Rbpjκ cKO mice 
(F) and appears increased within both the anterior and posterior hypothalamus in NICD Tg mice 
(G). H, I: A schematic summarizing Hes1 (red dash) and Hes5 (blue dot) expression within the 
anterior and posterior hypothalamus in control, Rbpjκ cKO, Hes1 null and NICD Tg mice. Scale 
bar, 50µm.     
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Fig. 3.2. Persistent activation of hypothalamic Notch affects expression of patterning 
factors within the hypothalamus and Rathke’s pouch. Hematoxylin and eosin (H&E) staining 
in sagittal sections at e10.5 shows the morphology of control (A) and NICD Tg (B) hypothalamic 
(Hyp) and pituitary regions, displaying loss of the infundibulum (INF) and thin RP in NICD Tg 
mice. Expression of Shh mRNA, detected by in-situ hybridization, is restricted to the anterior 
hypothalamus in control mice (brackets, C), while boundaries of Shh expression are disrupted in 
NICD Tg mice (brackets, D).  Additionally, persistent expression of Notch1 results in loss of 
OTX2 expression within the INF (brackets, F) compared to controls (brackets, E). Another 
important hypothalamic patterning gene, Fgf10, is normally expressed throughout the INF in 
control mice (G), and has reduced expression in NICD Tg animals (H). Immunohistochemistry 
shows that expression of p-ERK, which is uniformly expressed in RP of control animals (I), is 
lost on the caudal side of RP in Tg animals (J). Scale bar, 50µm.     
 
&RQWURO 7J
* +
9'
,1)
53
$ %
+
	
(
)J
I

2
7;

S
(5
.
& '
( )
, -
S
60
$
'
6K
K
&RQWURO 1,&'7J
2
7;

+
	
(
)J
I

S
(5
.
'&
%$
+*
-,
)(
,1)
53
 77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3. Persistent hypothalamic Notch expression affects survival of pituitary 
progenitors at e10.5. Control sagittal sections at e10.5 show LHX3 immunopositive cells within 
Rathke’s pouch (RP), allowing for proper pituitary induction (A). NICD Tg animals display 
reduced LHX3 expression, specifically on the caudal and dorsal aspect of RP (B). ISL1 
immunopositive cells, restricted to the ventral aspect of RP in control animals (C), are instead 
expressed uniformly in NICD Tg animals (D). TUNEL-reactive cells, representing cells 
undergoing cell death, are not present in control pituitaries at e10.5 (E), but are present in the 
caudal side of RP in Tg animals (F). The percent of immunoreactive phospho-histone-h3 (PH3) 
cells over total DAPI-postitive cells is significantly reduced in NICD Tg pituitaries (H, 34.7±0.6%, 
p=0.03) compared to control pituitaries (G, 42.1±1.9%). Scale bar, 50µm. 
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Fig. 3.4. Persistent hypothalamic Notch activation disrupts pituitary morphology but not 
hormone specification at e16.5. Hematoxylin and eosin (H&E) staining reveals proper anterior 
lobe (AL), intermediate lobe (IL) and posterior lobe (PL) morphology in coronal pituitary sections 
at e16.5 (A, anterior; C, posterior). In contrast, NICD Tg pituitaries have altered pituitary shape 
with lack of IL distinction and no PL formation (B, anterior; D, posterior). In control pituitaries, 
luteinizing hormone (LH; E), growth hormone (GH; G), thyroid stimulating hormone (TSH; I), 
proopiomelanocortin (POMC; K) are specified by e16.5. NICD Tg pituitaries also display 
specification of these hormones (F, H, J, L). Scale bar, 50µm. 
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Fig. 3.5. Activated Notch in the developing hypothalamus affects intermediate lobe (IL) 
specification at e16.5. Coronal sections display SOX2 immunopositive cells in the IL of control 
animals (A), and SOX2 immunopositive cells are also present in the region surrounding the cleft 
in NICD Tg pituitaries (B). The IL specific marker, PAX7, is present throughout the IL of control 
pituitaries (C), but is absent in NICD Tg pituitaries (D). POMC derivatives are found in the IL of 
control animals (E) and immunoreactive POMC cells are reduced in the region above the cleft in 
NICD Tg animals (F). Control animals show restriction of PIT1 from the IL (G), while NICD Tg 
pituitaries display PIT1 expression within the region superior to the cleft (H). Additionally, growth 
hormone (GH) cells, a lineage requiring PIT1 expression, are restricted from the IL in control 
pituitaries (I) and also from the region superior to the cleft in NICD Tg pituitaries (J). Scale bar, 
50µm. 
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Fig. 3.6. Persistent activation of hypothalamic Notch results in maintained abnormal pituitary 
morphology, reduced pituitary size but does not affect hormone specification at 8 postnatal weeks. 
Pituitary photographs taken within the heads of control mice reveal the anterior lobe (AL), intermediate lobe 
(IL), and posterior lobe (PL; A). NICD Tg mice display a dramatic reduction in pituitary size, as well as 
elongated pituitary shape and a lack of distinct IL and PL lobes (B). Hematoxylin and eosin (H&E) staining 
shows morphology of control (C) and NICD Tg (D) pituitaries.  In control pituitaries, growth hormone (GH; E), 
thyroid stimulating hormone (TSH; G) and proopiomelanocortin (POMC, I) are specified appropriately in the AL 
and IL. NICD Tg animals also display specification of these hormones in the AL, but lack a region that 
resembles an IL or PL (F, H, J). Arginine vasopressin (AVP), found exclusively in the PL of control animals (K), 
is detected in the presumed AL of NICD Tg pituitaries (L). SOX2 immunopositive cells are present in the AL 
and IL of control animals (M) and within the AL of NICD Tg pituitaries (N). Higher magnification reveals 
cytoplasmic SOX2 immunolocalization in NICD Tg pituitaries (P, arrow), compared to immunostaining localized 
to the nucleus in controls (O, arrow). Scale bar, 250µm (A-D), 50µm (E-P).  
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CHAPTER 4: NOTCH/RBPJK SIGNALING REGULATES PROGENITOR 
MAINTENANCE AND DIFFERENTIATION OF HYPOTHALAMIC ARCUATE 
NEURONS2 
ABSTRACT 
 The hypothalamic arcuate nucleus (Arc), containing proopoiomelanocortin 
(POMC), neuropeptide Y (NPY) and growth hormone releasing hormone (GHRH) 
neurons, regulates feeding, energy balance and body size. Dysregulation of this 
homeostatic mediator underlies diseases ranging from growth failure to obesity. Despite 
considerable investigation regarding function of Arc neurons, mechanisms governing 
their development remain unclear. Notch signaling factors such as Hes1 and Mash1 are 
present in hypothalamic progenitors that give rise to Arc neurons. However, how Notch 
signaling controls these progenitor populations is unknown. To elucidate the role of 
Notch signaling in Arc development, we analyzed conditional loss of function mice 
lacking a necessary Notch co-factor, Rbpjκ, in Nkx2.1-cre expressing cells (Rbpjκ cKO), 
as well as mice with expression of the constitutively active Notch1 intracellular domain 
(NICD) in Nkx2.1-cre expressing cells (NICD Tg). We found that loss of Rbpjκ results in 
absence of Hes1 but not Hes5 within the primordial Arc at e13.5. Additionally, Mash1 
expression is increased, coincident with increased proliferation and accumulation of Arc 
neurons at e13.5. At e18.5, Rbpjκ cKO mice have few progenitors and show increased 
numbers of differentiated Pomc, NPY and Ghrh neurons. In contrast, NICD Tg mice 
have increased hypothalamic progenitors, show absence of differentiated Arc neurons 
and aberrant glial differentiation at e18.5. Subsequently, both Rbpjκ cKO and NICD Tg 
mice have changes in growth and body size during postnatal development. Taken 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 This chapter appeared in its entirety in Development, is reprinted with the permission of the publisher and 
is available from http://dev.biologists.org/ and using DOI: 10.1242/dev.098681. 	  
 82 
together, our results demonstrate that Notch/Rbpjκ signaling regulates the generation 
and differentiation of Arc neurons, which contribute to homeostatic regulation of body 
size.
 
INTRODUCTION 
The mammalian hypothalamus regulates essential and dynamic physiological 
functions, including growth, thermoregulation, metabolism, sleep, as well as reproductive 
and maternal behaviors (Krononberg et al., 2007; Michaud. 2001; Caqueret, et al. 2005). 
The hypothalamus is comprised of complex and networked sets of nuclei, which regulate 
homeostatic function through production and delivery of neuropeptide to distinct targets  
(Swanson, Sawchenko. 1983). A specific group of hypothalamic neurons, located in the 
arcuate nucleus (Arc), integrate peripheral endocrine and metabolic signals and project 
extensively to other brain regions in order to regulate energy balance and body size  
(Akimoto, et al. 2010).   
Developmental defects in the Arc and related hypothalamic nuclei within the 
ventral hypothalamus are thought to disrupt neuropeptide release and may contribute to 
multiple diseases, including obesity and related metabolic disorders  (Krude, et al. 1998; 
Caqueret, et al. 2005; O'Rahilly. 2009). Previous studies have identified morphogens 
and genes responsible for the patterning of cells along the developing dorsoventral and 
anterioposterior axes  (Dale, et al. 1997; Lee, et al. 2006; Ohyama, Das, Placzek. 2008; 
Blackshaw, et al. 2010; Shimogori, et al. 2010; Morales-Delgado, et al. 2011; Alvarez-
Bolado, Paul, Blaess. 2012). Additional studies have identified genes that are necessary 
for specification of neuronal subtypes within the ventral hypothalamus (Li, et al. 1996; 
Acampora, et al. 1999; Marin, Anderson, Rubenstein. 2000; McNay, et al. 2006; Pelling, 
et al. 2011). However, signals that direct expression of these factors or directly control 
hypothalamic neurogenesis have not been identified.   
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Hypothalamic neurogenesis begins on embryonic day 10.5 (e10.5) in the mouse, 
peaking at e12.5  (Shimada, Nakamura. 1973; Ishii, Bouret. 2012). Cells that form the 
Arc are born along the anterior portion of the ventral surface, lining the third ventricle  
(Shimogori, et al. 2010). Recent studies have shown that Notch signaling pathway 
factors are found in Arc progenitors during embryonic development in vivo  (Kita, et al. 
2007; Pelling, et al. 2011; Shimogori et al., 2010) as well as in proliferating fetal 
hypothalamic neural stem/progenitor cells in vitro  (Desai, Li, Ross. 2011a; Desai, Li, 
Ross. 2011b).  
Activation of Notch signaling occurs when the Notch intracellular domain (NICD) is 
cleaved and NICD translocates to the nucleus and associates with the Rbpjκ 
Mastermind (MAM) complex  (Selkoe, Kopan. 2003). Within the nucleus, the 
NICD/Rbpjκ/MAM induces transcription of basic helix-loop-helix (bHLH) transcription 
factors encoded by Hes and Hey genes  (Iso, Kedes, Hamamori. 2003). However, 
adding complexity to the system, Notch can signal independently of Rbpjκ/MAM, Hes 
genes can be induced by signals other than Notch/Rbpjκ and Rbpjκ/MAM can also have 
transcriptional activity independent of Notch  (Martinez Arias, Zecchini, Brennan. 2002; 
Brennan, Gardner. 2002).  
Notch targets Hes1 and Hes5 are essential in regulating progenitor pool 
maintenance during development of the neocortex  (Hitoshi, et al. 2002; Yoon, et al. 
2004; Yoon, Gaiano. 2005). Loss of function studies have shown that loss of Hes1 and 
Hes5 result in progenitor depletion and promote premature neuronal differentiation  
(Yoon, Gaiano. 2005; Kageyama, et al. 2005). In contrast, increased or persistent 
activation of Notch1 promotes maintenance of a progenitor state and inhibits neuronal 
differentiation  (Gaiano, Nye, Fishell. 2000; Mizutani, Saito. 2005). Taken together with 
reports of Hes1 and Hes5 in the developing Arc (McNay et al., 2006; Pelling, et al. 2011; 
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Shimogori et al., 2010) we hypothesize that Notch/Rbpjκ signaling may play a role in 
maintaining progenitors and controlling differentiation of Arc neurons.  
During embryonic development cells migrate from the hypothalamic ventricular 
zone (HVZ) that surrounds the ventral portion of the third ventricle in order to form the 
Arc by e16.5  (Shimada, Nakamura. 1973; Bayer, Altman. 1987; Ishii, Bouret. 2012). 
One of the major functions of the Arc is to respond to food intake and energy 
expenditure. Energy related hormone signals such as leptin are sensed by anorexic 
proopoiomelanocortin (POMC)/cocaine and amphetamine-regulated transcript (CART) 
neurons and orexic neuropeptide Y (NPY)/Agouti-related peptide (AgRP) neurons. 
POMC and NPY neurons regulate feeding behavior and are crucial to maintaining proper 
energy balance and homeostasis  (Srinivas, et al. 2001; Broberger. 2005; Morton, et al. 
2006).  An additional subtype of neurons, growth hormone releasing hormone (GHRH) 
neurons, are present in the Arc and regulate body size and growth by controlling release 
of growth hormone from the pituitary gland  (Grossman, Savage, Besser. 1986; Bouyer, 
et al. 2007).  
Despite the functional importance of the Arc, little is known about the factors that 
control Arc neuron differentiation during development. To explore if Notch/Rbpjκ 
signaling is involved in the development of the Arc neurons, we utilized a loss and gain 
of function approach.  We analyzed mice with loss of Rbpjκ as well as mice with 
persistent expression of NICD specifically within Nkx2.1-positive cells. Neurons and glia 
that form the Arc originate from the Nkx2.1 positive region of the proliferating third 
ventricle  (Shimada, Nakamura. 1973; Shimogori, et al. 2010) and fate mapping studies 
have shown that Nkx2.1 cells and their lineages are expressed within Arc neurons  (Yee, 
et al. 2009). Given the timing and spatial restriction of Nkx2.1 expression  (Lazzaro, et 
al. 1991; Nakamura, et al. 2001; Ring, Zeltser. 2010), these loss of function (Rbpjκ cKO) 
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and gain of function (NICD Tg) mice are a useful model for examining Arc Notch/Rbpjκ 
pathway loss as well as constitutive Notch activation.   
We found that loss of Rbpjκ results in absence of Hes1 expression and 
increased Mash1 expression, corresponding with increased proliferation and 
differentiation of Arc neurons at e13.5. At e18.5, Rbpjκ cKO mice have few progenitors 
and increased numbers of differentiated Arc neurons.  In contrast, NICD Tg mice have 
an expanded hypothalamic progenitor population and absence of differentiated Arc 
neurons at e18.5. Our results suggest that Notch/Rbpjκ signaling regulates the 
generation and differentiation of Arc neurons in the developing hypothalamus.  
MATERIALS AND METHODS 
Mice  
RosaNotchICD floxed mice  (Murtaugh, et al. 2003) purchased from Jackson Laboratories 
(Bar Harbor, ME, USA) and Rbpjκ floxed mice (Dr. Tasuku Honjo,  (Han, et al. 2002) 
were bred to Nkx2.1-cre mice  (Lazzaro, et al. 1991; Xu, Tam, Anderson. 2008) 
purchased from Jackson Laboratories. Breeding colonies were generated at the 
University of Illinois at Urbana-Champaign (UIUC) and all animal procedures were 
approved by the UIUC Institutional Animal Care and Use Committee. Genotyping was 
performed as described previously  (Lazzaro, et al. 1991; Han, et al. 2002; Murtaugh, et 
al. 2003).  
Histology, immunohistochemistry and in situ hybridization  
RosaNotchICD/+ mice (NICD Tg Control), RosaNotchICD/+ Nkx2.1-cre+/cre (NICD Tg), Rbpjκfl/fl 
Nkx2.1-cre+/+ (Rbpjκ cKO Control), Rbpjκfl/fl Nkx2.1-cre+/cre (Rbpjκ cKO) mice were 
collected at e13.5, e18.5 and day of parturition (p1) and fixed in 3.8% formaldehyde 
solution (Fisher, Pittsburg, PA, USA) in phosphate buffered saline (PBS). All 
experiments included littermate controls for each genotype. Samples were dehydrated, 
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embedded and sectioned as previously described (Goldberg et al., 2011). A hematoxylin 
and eosin stain was used to observe cell morphology. To prepare slides for 
immunofluorescence, slides were deparaffinized in xylene and rehydrated in ethanol and 
PBS followed by a 10-min boil in 10 mM citric acid (pH 6) for slides incubated with anti-
SOX2, anti-Ki67, anti-Nestin, anti-BrdU, anti-NPY, anti-GFAP and anti-TH antibody. 
Slides were then incubated in normal donkey serum [5% (wt/vol)] diluted in 
immunohistochemistry block, which consists of PBS, BSA (3%), and Triton X-100 
(0.5%), followed by overnight incubation at 4°C with a primary antibody diluted in block 
against the desired peptide: mouse anti-BrdU (BD Pharmingen, San Jose, CA, USA; 
1:150), rat anti-Ki67 (DAKO, Carpinteria, CA, USA; 1:100), rabbit anti-SOX2 antibody 
(Millipore, Billerica, MA, USA; 1:500), rabbit anti-GFAP (1:500; Neomarkers, Fremont, 
CA, USA), rabbit anti-NPY (1:10,000; Peninsula Labs, San Carlos, CA,USA),   rabbit 
anti-TH (Millipore, Billerica, MA, USA; 1:1000), mouse anti-Nestin (Developmental 
Studies Hybridoma Bank, Iowa City, Iowa, USA; 1:100). Donkey-derived mouse, rat and 
rabbit secondary antibodies conjugated to biotin (Jackson ImmunoResearch; West 
Grove, PA, USA) were diluted to 1:200 and incubated with sections for 1 h. Slides were 
then incubated with tertiary antibodies, streptavidin conjugated to either cy2 or cy3 
fluorophore (Jackson ImmunoResearch) for 1 h. All sides were counterstained with 4′,6-
diamidino-2-phenylindole dihydrochloride (DAPI; Sigma, St. Louis, MO, USA) at 1:1000 
(stock 1 mg/ml) and mounted using aqueous fluorescence mounting media.  
 Cell death was determined by the TUNEL (Terminal deoxynucleotidyl Transferase 
Biotin-dUTP Nick End Labeling) method using the in situ cell death detection kit (Roche, 
Indianapolis IN, USA) according to the manufacturer’s protocol. 
 For in situ hybridization (ISH), embryos were collected and embedded in paraffin 
as they were for immunohistochemistry. The in situ probes used were Hes1, Hes5, 
Notch2  (Akazawa, et al. 1992), Mash1  (Carninci, et al. 2003), Notch1 (gift from Dr. 
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Andy Groves), Nkx2.1 (gift from Dr. Douglas Epstein), Rax (gift from Dr. Seth 
Blackshaw, Shimogori et al., 2010), Pomc (gift from Dr. Malcom Low,  (Japon, 
Rubinstein, Low. 1994) Ghrh (gift from Dr. Paul Le Tissier, (Balthasar, et al. 2003; Le 
Tissier, et al. 2005)Probes were linearized and transcribed with polymerase in the 
presence of digoxigenin-labeled nucleotides. The slides were rehydrated with xylene, 
followed by a gradient of ethanol before equilibrating in PBS. After washing in PBS, the 
slides were then acetylated, after which a 1:1 solution of 2× hybridization solution 
(Sigma Chemical Co., St. Louis, MO, USA) and deionized formamide was put on each 
slide, and the slides were incubated at their respective hybridization temperature for 
several hours. The probes were then denatured for 3 min and then put on the slides 
under a coverslip overnight at hybridization temperature. Slides were then put in a 50% 
formamide 0.5 × standard sodium citrate solution at hybridization temperature for 1 h. 
The slides were then blocked with 10% heat-inactivated sheep serum in Tris-buffered 
saline containing 2% BSA and 0.1% Triton X-100, followed by the application of the 
antidigoxigenin antibody conjugated to alkaline phosphatase (Roche, Indianapolis, IN, 
USA). NBT-BCIP (Roche, Indianapolis, IN, USA; 1:50) was added overnight for 
detection. Samples were then visualized at ×200 magnification using a DM 2560 
microscope (Leica, Wetzlar, Germany) and images were obtained using Q Capture Pro 
software (QImaging, Surrey, British Columbia, Canada) and processed using Photoshop 
software (Adobe, San Jose, CA, USA).  
Pomc and NPY Cell counts  
Pomc-positive and NPY-immunopositive cell counts were performed on coronal sections 
throughout the rostrocaudal extent of the Arc at e18.5 in NICD Tg control, NICD Tg, 
Rbpjκ cKO control, and Rbpjκ cKO mice (n=4). For each animal, a total of six slides, 
three sections per slide, were chosen approximately 50 µm apart spanning the 
presumptive Arc. The number of Arc Pomc-positive and NPY-immunopositive cells were 
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counted in each section. The mean and standard deviation of these averages was then 
obtained for both groups and was graphed as the average percent of Pomc-positive and 
NPY-immunopositive cells per group. Two-tailed t-tests were performed in Microsoft 
Excel to determine statistical significance. 
Measurement of postnatal body weight  
NICD Tg control, NICD Tg, Rbpjκ cKO control, and Rbpjκ cKO (n=8) male and female 
mice were weighed weekly from the first week of age to 8 weeks. Mice were weaned at 
3 weeks and given ad lib access to normal chow (5% fat). Means for sex-matched 
individuals from each genotypic group were obtained and paired t-tests were used with 
alpha level of 0.05 to determine difference between the weights of control and transgenic 
mice in each group (Microsoft Office Excel 2011). Representative photographs were 
taken of female mice at 2 weeks and 8 weeks.  
RESULTS 
Notch receptors and ligands are present within the developing Arc  
 In order to determine the localization of Notch receptors and ligands in the 
developing Arc, we performed in situ hybridization probing for the Notch receptors 
Notch1 and Notch2, as well as Notch targets Hes1 and Hes5 in sagittal sections 
throughout the ventral hypothalamus at embryonic day 13.5 (e13.5).  Sagittal sections of 
the ventral hypothalamic midline contain the anterior ventral (AV) and posterior ventral 
(PV) hypothalamus (Fig. 4.1A). Nkx2.1, a putative marker of the ventral hypothalamus, is 
expressed throughout the AV and PV (Fig. 4.1B). Pomc expression within the AV 
hypothalamus delineates the Arc region within the AV (Fig. 4.1C). Both Notch1 and 
Notch2 transcripts are localized to hypothalamic ventricular zone (HVZ) of the Arc (Fig. 
4.1D, E). The Notch target Hes1 is found within both the AV and PV (Fig. 4.1F), while 
Hes5 mRNA is localized to the Arc HVZ and not found in the PV (Fig. 4.1G). We also 
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examined expression of an additional Notch target, Hey1, and found that it was not 
expressed within the ventral hypothalamus at e13.5 (data not shown). Our results 
indicate that Notch receptors as well as targets Hes1 and Hes5 are localized to the HVZ 
of the developing Arc at e13.5 and may contribute to development of the nucleus.   
Loss of Rbpjκ  and persistent expression of Notch1 affects Hes1 expression and 
disrupts Arc morphology  
 In order to determine how Notch signaling affects hypothalamic progenitors within 
the Arc, we generated a mouse model to manipulate Notch/Rbpjκ signaling in Nkx2.1-
positive cells. We found that Nkx2.1 expression overlaps with expression of Notch 
signaling receptors and targets (Fig. 4.1) and Nkx2.1-positive cells and their lineages are 
broadly expressed in neuronal subtypes within the Arc  (Yee, et al. 2009). We then 
examined mice with loss of the Notch1 receptor  (Yang, et al. 2004) in Nkx2.1 cells and 
found that Arc progenitors were not affected (data not shown), indicating that loss of 
Notch1 alone does not affect Arc formation. We therefore crossed Rbpjκ floxed mice  
(Han, et al. 2002) with Nkx2.1-cre mice  (Lazzaro, et al. 1991) (Rbpjκ cKO) to determine 
how loss of the necessary Notch co-factor Rbpjκ would affect Arc progenitors. 
Additionally, we crossed RosaNotchICD/+ mice (Murtaugh et al., 2003) with Nkx2.1-cre mice 
to generate gain of function transgenic (NICD Tg) mice and examine how persistent 
expression of the active Notch1 intracellular domain would affect Arc development.  
 We found that Rbpjκ cKO mice have an expanded Arc region with a variably sized 
ventricular zone (Fig. 4.2B) and NICD Tg mice have a reduced Arc region (Fig. 4.2C) 
compared to controls (Fig. 4.2A). Notch1 is present within the Arc HVZ of control (Fig. 
4.2D), Rbpjκ cKO mice (Fig. 4.2E) and increased in NICD Tg mice (Fig. 4.2F). Notch2 
mRNA is also expressed within the Arc HVZ of control (Fig. 4.2G), Rbpjκ cKO (Fig. 
4.2H) and NICD Tg (Fig. 4.2I) mice. The Notch target Hes1 is expressed within the 
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control Arc (Fig. 4.2J), absent from Rbpjκ cKO mice (Fig. 4.2K) and is present within the 
Arc of NICD Tg mice (Fig. 4.2L). Hes5 mRNA is expressed along the Arc HVZ of control 
animals (Fig. 4.2M), remains expressed in Rbpjκ cKO mice (Fig. 4.2N) and is also 
expressed in NICD Tg mice (Fig. 4.2O). Taken together, our results indicate that loss of 
Rbpjκ results in absence of Hes1 and not Hes5, suggesting that Hes5 expression may 
be independent of Notch/Rbpjκ signaling in the developing Arc.  
Notch signaling affects Arc progenitor population maintenance and Pomc 
differentiation 
 To investigate the function of Notch/Rbpjκ signaling in Arc progenitors, we 
probed for markers of progenitor cells, proliferation, cell death and differentiation. H&E 
staining shows expansion of the Arc region found in Rbpjκ cKO mice (Fig. 4.3B) and 
reduction of the Arc region found in NICD Tg mice (Fig. 4.3C) compared to controls (Fig. 
4.3A). Importantly, the Arc HVZ is maintained within all genotypes at this age (dashed 
lines). The ventricular zone is populated by progenitors  (Shimada, Nakamura. 1973; 
Altman, Bayer. 1978; Bayer, Altman. 1987), therefore, we examined sex determining 
region-Y-box 2 (SOX2) expression, a transcription factor essential for inhibiting cell 
differentiation to maintain pluripotency and a known marker of neural progenitor cells  
(Episkopou. 2005; Masui, et al. 2007). We found that SOX2 is present within the 
ventricular zone and Arc of control (Fig. 4.3D), Rbpjκ cKO (Fig. 4.3E), and NICD Tg (Fig. 
4.3F) mice at e13.5.  
 Proliferation of progenitors is an important aspect of progenitor maintenance and 
we therefore examined Ki67-immunopositive cells lining the third ventricle to detect 
actively dividing cells. We found that few cells in the Arc are Ki67-immunopositive in 
controls (Fig. 4.3G), while Ki67-immunopositive cells appear increased within the 
ventricular zone (dashed lines) and diffusely expressed throughout the increased Arc 
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region of Rbpjκ cKO mice (Fig. 4.3H). We also found that persistent expression of Notch 
results in apparently increased Ki67-immunopositive cells within the dorsal aspect of the 
Arc but dramatically reduced Ki67-immunopositive cells within the ventral region (Fig. 
4.3I).  
 To investigate the composition of the Arc in both Rbpjκ cKO and NICD Tg mice, 
we probed for expression of Pomc, the first neuron type to differentiate in the 
presumptive Arc region  (McNay et al., 2006; Padilla, Carmody, Zeltser. 2010; Pelling, et 
al. 2011). Pomc is expressed within the Arc of control mice at e13.5 (Fig. 4.3J), diffusely 
expressed within the expanded Arc of Rbpjκ cKO mice (Fig. 4.3K) and expressed in few 
cells within NICD Tg mice (Fig. 4.3L).  
 Given the increase in cell proliferation and differentiation observed in the Arc of 
Rbpjκ cKO mice, we investigated the expression of Mash1, which is repressed by Hes1  
(Sasai, et al. 1992) and is known to promote both progenitor proliferation  (Castro, et al. 
2011) and neuronal commitment  (Casarosa, Fode, Guillemot. 1999). We found that 
Mash1 is increased in Rbpjκ cKO mice (Fig. 4.3N) and reduced within the ventral aspect 
of the Arc in NICD Tg mice (Fig. 4.3O) compared to controls (Fig. 4.3M). These data 
suggest that in the absence of Notch/Rbpjκ, progenitor proliferation is increased and 
there is robust differentiation into Pomc expressing neurons, whereas persistent Notch1 
expression suppresses differentiation.  
 The regulation of progenitor cells through apoptosis is an important 
developmental event that occurs during the transition from neural progenitor to 
differentiated neuronal subtype  (Price, et al. 1997; Blaschke, Weiner, Chun. 1998).   In 
fact, loss of Notch signaling through Hes1 can induce apoptosis  (Jensen, et al. 2000; 
Raetzman, Cai, Camper. 2007). We therefore used TUNEL to assay for cell death to 
determine if Notch/Rbpjκ may be affecting progenitor survival within the Arc of Rbpjκ 
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cKO and NICD Tg mice. We found that there are no TUNEL-positive cells within the Arc 
of control (Fig. 4.3P) or NICD Tg mice (Fig. 4.3R), while TUNEL-positive cells aberrantly 
line the ventricular zone within the Arc of Rbpjκ cKO mice (Fig. 4.3Q) at e13.5. 
Therefore, our data suggest that Notch/Rbpjκ signaling is necessary for progenitor 
survival in the Arc.  
Notch signaling is required for proper formation of the hypothalamic ventricular 
zone   
 We have shown that progenitors within the Arc HVZ express Notch receptors and 
downstream targets at e13.5 (Fig. 4.1, 4.2) and that Notch/Rbpjκ affects proliferation, 
differentiation and cell survival of Arc progenitors at e13.5. In order to determine how 
loss of Notch/Rbpjκ and persistent expression of NICD would affect Arc progenitors later 
in embryonic development, we examined the HVZ of Rbpjκ cKO and NICD Tg mice at 
e18.5. We found that loss of Notch/Rbpjκ causes a complete loss of the HVZ (dashed 
box; Fig. 4.4B), which correlates with the cell death observed at e13.5 in this region. In 
contrast, NICD Tg mice display an apparent expansion of HVZ cells (Fig. 4.4C) 
compared to controls (Fig. 4.4A). In parallel, SOX2 immunostaining reveals a loss of 
SOX2-immunopositive progenitors lining the third ventricle in Rbpjκ cKO mice (Fig. 4.4E) 
compared to controls (Fig. 4.4D). In contrast, persistent expression of Notch results in an 
expanded HVZ comprised of SOX2-immunopositive cells in NICD Tg mice (Fig. 4.4F).  
 To confirm that the changes observed with SOX2 expression were reflective of 
neural progenitors, we examined Nestin expression and found that the Nestin-
immunopositive cells that line the third ventricle are lost in Rbpjκ cKO mice (Fig. 4.4H) 
compared to controls (Fig. 4.4G), while NICD Tg mice show an expansion of Nestin-
immunopositive cells in the HVZ (Fig. 4.4I). Similarly, mRNA expression of the 
hypothalamic-specific progenitor marker Rax is lost in Rbpjκ cKO mice (Fig. 4.4K), and 
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expanded in NICD Tg mice (Fig. 4.4L) compared to controls (Fig. 4.4J). Taken together, 
these results suggest that Notch/Rbpjκ signaling is required for survival and 
maintenance of progenitors as well as progenitor number in the Arc HVZ.  
Persistent expression of Notch holds hypothalamic cells in the hypothalamic 
ventricular zone   
  We found that persistently activated Notch increases the population of cells 
found within the HVZ at e18.5 (Fig. 4.4). In order to determine if the increased HVZ cell 
population is due to a continuing increase in HVZ cell genesis, we examined the 
expression of the proliferation marker Ki67.  We found that Ki67-immunopositive cells 
were not present in control (Fig. 4.5A) or NICD Tg mice (Fig. 4.5B), indicating activated 
Notch is not sufficient to induce proliferation at postnatal day 1 (p1).  
 An alternate possibility is that the increase in cells within the HVZ in NICD Tg 
mice is due to a build up of cells that have not migrated to hypothalamic nuclei. In order 
to test this hypothesis, we injected control and NICD Tg mice with BrdU, a thymidine 
analog that is incorporated into newly synthesized DNA of replicating cells (Kuhn et al., 
1996), at e12.5. We then performed BrdU-immunohistochemistry at p1 to determine the 
location of cells born at e12.5, the peak of hypothalamic neurogenesis (Ishii et al., 2012). 
We found that BrdU-immunopositive cells are present within HVZ and the Arc (dashed 
circle) in control mice (Fig. 4.5C), but are present only within the HVZ in NICD Tg mice 
(Fig. 4.5D). Taken together with data showing increased Arc proliferation in NICD Tg 
mice at e13.5 (Fig. 4.3I), these results indicate that the increase in the ventral HVZ 
population is due to both proliferation during early embryonic development, as well as 
cells being retained in the HVZ.  
 In addition to its role in progenitor maintenance, Notch signaling is also known to 
promote glial differentiation in other tissues  (Furukawa, et al. 2000; Gaiano et al., 2000; 
Gaiano, Fishell. 2002). We therefore examined the expression of glial fibrillary acidic 
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protein (GFAP) to determine if the cells within the HVZ in NICD Tg mice adopted a glial 
fate. We found that many cells within the HVZ in NICD Tg are GFAP-immunopositive 
(Fig. 4.5F), compared to HVZ cells in controls, which do not yet express GFAP at this 
stage of development (Fig. 4.5E). Our data indicate that persistent Notch expression 
leads to accumulation of progenitor cells within the developing Arc HVZ that aberrantly 
assume a glial fate.  
Notch signaling is required for proper differentiation of arcuate neurons  
            By e18.5, a subset of progenitors within HVZ have migrated to the Arc and 
differentiated into neuronal subtypes  (McNay, et al. 2006; Yee, et al. 2009; Pelling, et al. 
2011). Given that loss and gain of Notch dramatically affects Arc progenitors at e18.5, 
we examined the differentiation of Arc neurons at the same developmental timepoint. 
We found that loss of Notch increased the number of Pomc-positive cells in the Arc (Fig. 
4.6B, M) compared to controls (Fig. 4.6A, M). In contrast, persistent activation of Notch 
results in absence of differentiated Pomc neurons (Fig. 4.6C). The number of NPY-
immunopositive cells was also increased in Rbpjκ cKO mice (Fig. 4.6E, M) compared to 
controls (Fig. 4.6D, M), while NICD Tg mice show no NPY-immunopositive cells within 
the presumptive Arc. Ghrh-positive and TH-immunopositive neurons are also increased 
in Rbpjκ cKO mice (Fig. 4.6H, K) compared to controls (Fig. 4.6G, J), while NICD Tg 
mice have no apparent differentiation of Ghrh-positive or TH-immnopositive neurons 
(Fig. 4.6I, L). These data indicate that Notch/Rbpjκ signaling regulates Arc neuron 
number and that it must be turned off for Arc neuron differentiation to occur.  
Body size is altered in mice with loss and gain of Notch signaling in the ventral 
hypothalamus.  
            We found that loss of Notch/Rbpjκ signaling and persistent Notch expression in 
vivo affects differentiation of Pomc and NPY neurons, as well as Ghrh neurons, which 
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regulate feeding and body size, respectively. In order to determine the long-term 
physiological effects of disrupted Arc formation, we measured postnatal body weight of 
cKO and Tg mice and their controls for 8 weeks. We found that Rbpjκ cKO mice weigh 
significantly more than Rbpjκ cKO controls at week 7 and week 8. Additionally, NICD Tg 
mice appear to have a reduced length and weigh significantly less than their controls at 
weeks 3, 4 and 5. However, despite their apparent reduction in body length, by week 7 
NICD Tg mice have similar body weight compared to controls. These results suggest 
that manipulations in Notch signaling that result in changes in differentiation of neurons 
that control body size and metabolism have significant consequences on body weight in 
vivo.  
DISCUSSION 
 Development of the hypothalamus arises from coordinated signaling that induces 
patterning genes, which allow formation of neuronal clusters with distinct function. The 
development of the Arc can be divided into three main events during embryogenesis: 
hypothalamic regionalization (before e10.5), specification and differentiation of Arc 
progenitors (e10.5-15.5), and organization of hypothalamic nuclei (e16.5-e18.5)  
(Caqueret, et al. 2005; McClellan, Parker, Tobet. 2006; Shimada and Nakamura, 1973).  
Once regionalized, a subset of multipotent Sox2 and Rax Arc progenitors must exit the 
cell cycle and undergo neuronal differentiation  (Lu, et al. 2013). The expression of 
bHLH proneural genes such as Mash1 is necessary to promote differentiation of Arc 
neurons into neuronal subtypes  (Kim, et al. 2008; McNay et al., 2006) and generate a 
distinct nucleus.  
 Although certain factors necessary for Arc development such as Rax and Mash1 
have been identified, how these signals are integrated to direct differentiation of Arc 
neurons and subsequent Arc nucleus formation is unknown. The current study examines 
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the possibility that Notch signaling is the critical mediator of progenitor cell cycle exit and 
differentiation. We found that Notch/Rbpjκ signaling, acting through activation of Hes1, 
maintains Arc progenitor number and survival, inhibits Arc neuronal differentiation and is 
sufficient induce precocious astroglial differentiation within the Arc ventricular zone (see 
Fig. 4.8). 
 An important finding is that loss of Rbpjκ resulted in loss of Hes1 but not Hes5 
(Fig. 4.2), suggesting that Hes5 expression may be independent of Notch/Rbpjκ 
signaling in the Arc. It is well established that Hes1 expression can be regulated by 
Notch/Rbpjκ-independent signaling before e8.5  (Hatakeyama, et al. 2004; Kageyama, 
et al. 2005). Additionally, Rbpjκ-independent expression of Notch factors, including Hes 
genes, can be mediated by members of the BMP  (Dahlqvist, et al. 2003; Itoh, et al. 
2004), TGFβ  (Ross, Kadesch. 2001; Blokzijl, et al. 2003; Kluppel, Wrana. 2005), 
WNT/β-CATENIN  (Axelrod, et al. 1996; Hayward, et al. 2005) and SHH (Wall, et al. 
2009) pathways throughout embryonic development.  However, only a few studies have 
shown that Hes5 can be modulated by Notch/Rbpjκ-independent signaling occurring at 
two distinct time points:  before e8.5  (Donoviel, et al. 1999)  (Hitoshi, et al. 2011) and 
during adult neurogenesis  (Matsuda, et al. 2012). Our study is the first to show that 
Hes5 expression may be regulated Rbpjκ-independent signaling during embryonic 
neurogenesis in vivo. Given that other Notch targets can be modulated by BMP, TGFβ, 
WNT/β-CATENIN and SHH, it is possible that the Hes5 expression observed in the 
absence of Rbpjκ may be mediated by one of these pathways in the developing Arc.  
 Our results suggest that Notch/Rbpjκ signaling mediated by Hes1 affects 
maintenance of the Arc progenitor pool by repressing Mash1. In the current study, loss 
of Hes1 results in robust Mash1 expression, cell proliferation, and increased Pomc 
differentiation (Fig. 4.3). The antagonistic expression and function of Hes1 and Mash1 
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are well established in other contexts. Hes1 is known to bind to the Mash1 promoter  
(Chen, et al. 1997) to prevent its transcriptional activation  (Sasai, et al. 1992). In fact, 
repression of proneural genes such as Mash1 is the proposed mechanism of Hes1 
induced inhibition of neuronal differentiation  (Kageyama, et al. 1997; Schuurmans, 
Guillemot. 2002; Kageyama, et al. 2005). Mash1, normally antagonized by Hes1, 
encourages progenitor proliferation  (Castro, et al. 2011) and rapidly induces cell cycle 
exit leading to neuronal commitment  (Casarosa, Fode, Guillemot. 1999). This suggests 
that in the current study, loss of Hes1 and increased Mash1 leads to increased cell 
proliferation and Arc differentiation in Rbpjκ cKO mice. Our results additionally show that 
persistent Notch activation results in reduced Mash1 expression and reduced Pomc 
differentiation in NICD Tg mice (Fig. 4.3), confirming that Notch/Rbpjκ is both required 
and sufficient within a Arc progenitor to repress Mash1 and maintain progenitor fate.  
 We also found that Rbpjκ cKO mice have aberrant cell death within the Arc at 
e13.5. The observed cell death within the Arc ventricular zone could be due to Hes1 
loss. Importantly, loss of Hes1 reduces the self-renewing ability of telencephalic 
progenitors and accelerates progenitors towards the neuronal lineage, resulting in an 
increased number of committed progenitors that follow an apoptotic fate  (Nakamura, et 
al. 2000). Although there is observable Arc progenitor apoptosis at e13.5, Rbpjκ cKO 
mice still maintain a population of SOX-2-positive progenitors, perhaps due to the 
sustained Hes5 expression observed in the Arc ventricular zone. Therefore, in our model 
of Rbpjκ loss, Hes5 acting independently of Rbpjκ may maintain a subset of Arc 
progenitors that are proliferating and differentiating due to increased Mash1 activity, and 
the absence of Hes1 may also contribute to some progenitor cell death at e13.5. In 
contrast, conditional deletion of Rbpjκ from the telencephalon and subsequent loss of 
both Hes1 and Hes5 results in complete depletion of ventricular zone progenitors, 
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coincident with a reduction in telencephalon size and accelerated neural commitment  
(Imayoshi, et al. 2010). Therefore, our results suggest a novel Rbpjκ-independent role of 
Hes5 in maintaining the Arc progenitor population that is not observed in other brain 
regions. Notably, by e18.5 Rbpjκ cKO mice no longer have progenitor cells lining the 
ventricular zone (Fig. 4.4). Loss of progenitors likely results from a combination of 
progenitor death observed at e13.5 as well as increased differentiation of progenitors to 
Pomc, NPY, TH and Ghrh neurons (Fig. 4.6).   
 We demonstrate that persistent expression of Notch leads to robust and 
sustained progenitor build-up within the ventricular zone (Fig. 4.4, 4.5) and subsequent 
lack of Arc neuron differentiation at e18.5 (Fig. 4.6). Previous reports have also 
observed that both overexpression of Hes1 and activated Notch signaling inhibits 
neuronal differentiation within the cortex (Ishibashi, et al. 1994). We also found that the 
expanded progenitor zone observed in NICD Tg mice is coincident with expanded 
SOX2-immunopositive and Nestin-immunopositive cells. SOX2 is an important factor in 
inhibiting cell differentiation and maintaining stem cell character  (Episkopou. 2005). In 
fact, the Notch intracellular domain (NICD), which is constitutively activated in the NICD 
Tg model reported here, is able to directly activate transcription of the SOX2 promoter  
(Ehm, et al. 2010). Notch overexpression can also activate the Nestin promoter  (Shih, 
Holland. 2006), which supports the observation of increased Nestin-immunnopositive 
cells in NICD Tg mice (Fig. 4.4). Taken together, our data suggest that persistent Notch 
signaling directly maintains cells in a progenitor state and does not allow for proper 
differentiation into Arc neurons.  
We show that Pomc, NPY and Ghrh neuron number relies on regulated levels of 
Notch signaling and that alterations in Notch signaling affect postnatal body weight and 
size. The reduced body length and body weight observed in NICD Tg mice may be in 
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part due to absence of Ghrh in the Arc (Fig. 4.6), which controls proper growth, as well 
as additional disruption of the hypothalamic-pituitary axis. Rbpjκ cKO mice have 
significantly increased body weight and increased Arc neurons, which likely contributes 
to the changes observed in postnatal body weight. Notably, Nkx2.1 is also expressed 
during early development within the thyroid gland and lung  (Lazzaro, et al. 1991), 
therefore, manipulations of Notch/Rbpjκ in Nkx2.1-positive regions outside of the 
hypothalamus may contribute to the body weight phenotype observed.  
 Our study establishes that Notch/Rbpjκ signaling within the developing Arc is 
crucial to establish the balance of progenitors and differentiated cells, including glia. 
Progenitor cells along the ventricular zone give rise to both neurons during embryonic 
development, as well as astrocytes after birth  (Qian, et al. 2000).  Notch/Rbpjκ signaling 
has been implicated in astrogliogenesis through demonstration of direct binding of 
NICD/Rbpjκ complex to the GFAP gene in vitro  (Ge, et al. 2002). Additionally, 
suppression of neurogenic bHLH factors, such as Mash1, is necessary for 
astrogliogenesis in the cortex  (Nieto, et al. 2001).  In contrast, activated Notch1 
promotes precocious astroglial differentiation in vitro  (Kohyama, et al. 2005). We show 
that persistent expression of Notch in vivo also results in precocious astroglial 
differentiation within the HVZ at p1 (Fig. 4.5). These data are the first to reveal that 
tightly controlled Notch signaling instructs proper timing of astroglial differentiation within 
the Arc in vivo.  
 We demonstrate that Notch/Rbpjκ signaling is important not only for astroglial 
differentiation within the Arc, but also contributes to maintenance of Arc progenitors and 
is required for restraining Arc neuron differentiation at the expense of progenitors. During 
development, Arc POMC and NPY neurons project to hypothalamic nuclei such as the 
paraventricular nucleus, establishing complex circuitry responsible for regulating feeding 
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behavior and energy metabolism. Identifying molecular pathways, such as Notch 
signaling, that control development of these neurons is crucial to understanding 
dysregulation of feeding and energy balance that occurs in metabolic disease. Recent 
studies have shown that the hypothalamic proliferative zone (HPZ) can undergo 
postnatal neurogenesis  (Shimogori, et al. 2010; Lee, Blackshaw. 2012; McNay, et al. 
2012) and is responsive to diet. In the adult mouse, the HPZ is enriched with Notch 
factors and future studies could utilize this mouse model to explore the effect of 
Notch/Rbpjκ signaling on the function of these neurogenic cells during postnatal 
development and adulthood. 
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Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.1. Localization of Notch receptors and target genes in the developing 
ventral hypothalamus at e13.5. Hematoxylin and eosin (H&E) staining performed on 
sagittal sections through the ventral midline at embryonic day 13.5 (e13.5) include the 
anterior ventral (AV) and posterior ventral (PV) hypothalamus (A). In situ hybridization at 
e13.5 shows that Nkx2.1 mRNA is expressed in hypothalamic cells within the anterior 
and posterior ventral midline (B). Pomc mRNA expression is detectable within the 
primordial arcuate nucleus (Arc; C). Additionally, Notch1 (D) and Notch2 (E) mRNAs are 
expressed in the AV hypothalamus as well as Notch targets Hes1 (F) and Hes5 (G). 
Scale bar = 50um. 
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Fig. 4.2. Loss of Rbpjκ  as well as persistent expression of Notch1 within the 
developing Arc affects Hes1 expression and disrupts Arc morphology at e13.5. 
H&E staining on sagittal sections at the ventral midline include the primordial Arc (A; 
dashed box). Rbpjκ cKO mice display an apparent expansion of the primordial Arc 
region (B), while NICD Tg mice show a reduction in Arc size (C). In situ hybridization 
shows that Notch1 is expressed in the ventricular zone of the Arc (D; dashed box). 
Notch1 expression is maintained in this region in Rbpjκ cKO mice (E) and is abundantly 
expressed within the Arc progenitor region of NICD Tg mice (F). Notch2 is also 
expressed in the within the Arc of control (G), Rbpjκ cKO (H) and NICD Tg (I) mice. 
Hes1 is expressed within the control Arc (J), absent from Rbpjκ cKO mice (K) and 
expressed within an expanded region within the Arc of NICD Tg mice (L). Surprisingly, 
Hes5 mRNA is expressed in the same region within the Arc of control animals (M), 
Rbpjκ cKO mice (N) and NICD Tg mice (O). Scale bar = 50um. 
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Fig. 4.3. Notch signaling affects Arc progenitor population maintenance and Pomc 
differentiation at e13.5. H&E staining on Arc sagittal sections shows the Arc of control 
(A), Rbpjκ cKO (B), and NICD Tg (C) mice, dashed lines indicate the more densely 
packed ventricular zone. Immunohistochemistry probing expression of the progenitor 
marker SOX2 shows that cells within the ventricular zone are SOX2-positive within 
control (D), Rbpjκ cKO (E), and NICD Tg (F) mice.  Some cells within the Arc HVZ are 
Ki67-immunopositive in control mice (G), more diffusely detected in the Arc of Rbpjκ 
cKO mice (outside of dashed lines, H) and restricted to a dorsal position in NICD Tg 
mice (I). Pomc mRNA is detected within the developing Arc in control mice (J). Rbpjκ 
cKO mice have a diffuse expression of Pomc-positive cells throughout the expanded Arc 
region (K), while NICD Tg mice have a reduction in Pomc-positive cells (L). Similarly, 
Mash1 mRNA is detected within the Arc HVZ of control mice (M), diffusely expressed 
within the Arc of Rbpjκ cKO mice (N), and reduced in NICD Tg mice (O). TUNEL 
staining reveals no cell death within the developing Arc in control (P) and NICD Tg mice 
(R). In contrast, TUNEL-positive cells within ventricular zone are found in Rbpjκ cKO 
mice (Q, dashed lines). Scale bar = 50um. 
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Fig. 4.4. Notch signaling is required for proper formation of the Arc hypothalamic 
ventricular zone at e18.5. Hematoxylin and eosin (H&E) staining on coronal sections 
show the third ventricle (3V) at the level of the Arc hypothalamic ventricular zone (HVZ) 
(A). Rbpjκ cKO mice show a loss of the Arc HVZ (B), while NICD Tg mice have an 
expanded Arc HVZ (C). SOX2 immunostaining shows a loss of SOX2-immunopositive 
cells lining the 3V in Rbpjκ cKO mice (E) compared to controls (D), while NICD Tg 
animals have an expanded Arc HVZ comprised of SOX2-immunopositive cells (F). 
Nestin-immunopositive cells label neuronal progenitors along HVZ (G), and this 
population is lost in Rbpjκ cKO mice (H) and expanded in NICD Tg mice (I). In situ 
hybridization using the hypothalamic progenitor marker Rax labels cells along the Arc 
HVZ in controls animals (J).  Rbpjκ cKO mice show few Rax-positive cells (K), while 
NICD Tg animals have an expanded Rax-positive region along the Arc HVZ (L). Scale 
bar = 50um.  
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Fig. 4.5. Hypothalamic cells born at e12.5 remain in the hypothalamic ventricular 
zone when Notch is persistently expressed. Coronal sections of the Arc at postnatal 
day 1 (p1) show that cells within the HVZ are not Ki67-immunopositive in control (A) or 
NICD Tg (B) mice, indicating that these cells are not proliferating at p1. BrdU-
immunohistochemistry was performed on mice at p1 that were injected with BrdU at 
e12.5.  BrdU-immunopositive cells are present within the ventricular zone and the 
arcuate nucleus (dotted circle) in control animals (C), but not in the Arc of NICD Tg mice 
(D). Arc HVZ cells of NICD Tg mice are GFAP-immunopositive (F), while control Arc 
HVZ cells do not express GFAP-immunopositive cells at this age (E). Scale bar = 50um.  
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Fig. 4.6. Rbpjκ-dependent Notch signaling is required for proper differentiation of 
Arc neurons at e18.5. In situ hybridization on coronal sections shows Pomc-positive 
cells in the arcuate nucleus (Arc) of control animals (47.1±4.2; A, M). Rbpjκ cKO mice 
have significantly more Pomc-positive neurons (84.7±8.1, p<0.001; B, M), while NICD Tg 
mice show no differentiation of Pomc-positive cells (C). NPY-immunopositive cells are 
present in the Arc of control mice (59.1±3.2; D, M), are significantly increased in number 
(87.7±9.7; p<0.001; E, M) in Rbpjκ cKO animals, and are not detected in NICD Tg 
animals (F). In situ hybridization reveals Ghrh-positive cells in the Arc of control animals 
(G), an apparent increase of these cells in Rbpjκ cKO mice (H) and no differentiation of 
these cells in NICD Tg mice (I). Similarly, TH-immunopositive cells are present in the Arc 
of control mice (J), appear increased in Rbpjκ cKO animals (K), while few cells are TH-
immunopositive in NICD Tg mice (L). (***p<0.001) 
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Fig. 4.7. Body size is altered in mice with loss of Rbpjκ-dependent Notch signaling 
as well as mice with persistent Notch expression in the Arc. Rbpjκ cKO mice 
appear to be normal in size and weight compared to controls at 2 postnatal weeks 
(2wks; A), while NICD Tg mice appear to be smaller in size (B). At 8 weeks Rbpjκ cKO 
(C) and NICD Tg (D) mice have increased body weight compared to littermate controls, 
yet NICD Tg mice appear shorter in length.  Male and female mice were weighed once 
per week until 8 postnatal weeks, female mice are pictured. Rbpjκ cKO mice begin 
increasing in body weight at week 5 and weigh significantly more than controls at week 7 
(p<0.05) and week 8 (p<0.05). NICD Tg mice have significantly lower body weight at 
week 3 (p<0.01), week 4 (p<0.05), and week 5 (p<0.01). (*p<0.05, **p<0.01) 
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Fig. 4.8. Notch/Rbpjκ  signaling regulates progenitor maintenance and 
differentiation of hypothalamic Arc neurons through Hes1 activation and 
repression of Mash1.  
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CHAPTER 5: CONCLUSION/DISCUSSION 
 Notch signaling is an evolutionarily conserved transmembrane signaling pathway 
that is crucial for cell lineage decisions during development, most notably for determining 
whether progenitor cells will adopt neural or glial fates (Bray. 2006) Expression of Notch 
signaling components, including the Notch target Hes1, have been localized to the 
developing hypothalamus and pituitary (Raetzman, et al. 2004; McNay, et al. 2006; 
Raetzman, Cai, Camper. 2007; Shimogori, et al. 2010; Pelling, et al. 2011). Previous 
work has shown that global loss of Hes1 affects formation of the posterior pituitary  
(Raetzman, Cai, Camper. 2007; Kita, et al. 2007). We demonstrate that global Hes1 loss 
additionally affects cell placement and projection of hypothalamic neurons to the pituitary  
(Chapter 2; Aujla, et al. 2011). The studies described in Chapter 3 and 4 investigate how 
Notch, and Hes1 in particular, controls hypothalamic neuron differentiation, and how 
alternations in hypothalamic patterning affect pituitary development.   
To determine the contribution of Notch signaling to hypothalamic development, 
we utilized mice with loss and gain of Notch function specifically within the developing 
ventral hypothalamus in cells that express Nkx2.1. The ventral hypothalamus can be 
divided into an anterior and posterior compartment (Zhao, et al. 2012). The anterior 
hypothalamus includes the Arcuate nucleus (Arc) and the posterior hypothalamus 
generates signals necessary for pituitary organogenesis (Treier, Rosenfeld. 1996; 
Takuma, et al. 1998; Ericson, et al. 1998; Norlin, Nordstrom, Edlund. 2000; Rosenfeld, et 
al. 2000; Zhu, Gleiberman, Rosenfeld. 2007).  
 We found that Notch signaling is an important regulatory pathway for neuron 
differentiation in the Arc (Chapter 4), a region of the hypothalamus that controls 
metabolic homeostasis. Additionally, regulated levels of Notch signaling and Notch 
target genes within the posterior hypothalamus are essential for proper hypothalamic 
patterning and subsequent pituitary development (Chapter 3). Proper pituitary 
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development is critical to the regulation of neuroendocrine processes such as growth, 
metabolism and reproduction. Future studies should further explore the mechanism of 
how distinct components of the Notch signaling pathway regulate hypothalamic 
progenitors and will be described in this chapter.  
Notch/Rbpjκ signaling within the anterior hypothalamus  
 A major finding of our studies is that Hes5 expression may be independent of 
Notch/Rbpjκ signaling in the developing Arc. Notch/Rbpjκ-independent expression of 
Notch factors, including Hes genes, can be mediated by members of the BMP 
(Dahlqvist, et al. 2003; Itoh, et al. 2004), TGFβ (Ross, Kadesch. 2001; Blokzijl, et al. 
2003; Kluppel, Wrana. 2005), WNT/β-CATENIN (Axelrod, et al. 1996; Hayward, et al. 
2005) and SHH (Wall, et al. 2009) pathways during embryonic development (see Fig. 
5.1). Therefore, Hes5 expression observed in the in the absence of Rbpjκ may be 
regulated by one of these pathways in the developing Arc.  
 Future studies should selectively eliminate Hes5 from the developing Arc to 
determine how this affects progenitor behavior and neuronal differentiation. In our study, 
proliferating progenitors were maintained within in the Hes5+ ventricular zone (Chapter 
4), indicating that Hes5 may play a redundant role of progenitor maintenance with Hes1 
in this context.  
 In contrast, we found that Notch/Rbpjκ signaling does control Hes1 expression 
and that this pathway directly maintains a progenitor fate in developing Arc cells. During 
the course of these studies, an existing hypothalamic cell line generated in the Belsham 
lab was found to have the progenitor marker Sox2 as well as the Notch target Hes1 
(Dhillon, et al. 2012). This cell line would be an ideal platform to identify novel Rbpjκ and 
Hes1 binding sites within hypothalamic cells. We could perform ChIP-seq experiments in 
these embryonic hypothalamic cell lines with and without the Notch inhibitor DAPT to 
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determine direct targets of Rbpjκ and Hes1 that are under the control of Notch. DAPT 
has been shown to effectively inhibit cleavage of the Notch intracellular domain (Dovey, 
et al. 2001) and prevent activation of the Notch response (Sastre, et al. 2001). 
Additionally, these findings could confirm our hypothesis that Rbpjκ and Hes1 may be 
transcriptionally regulating factors that promote a progenitor or glial fate, such as SOX, 
Nestin, Rax or GFAP, respectively.  
Notch is sufficient to maintain progenitor/glial fate within the developing Arc 
ventricular zone  
 An important finding described is that persistent Notch/Rbpjκ expression is 
sufficient to sustain anterior hypothalamic ventricular cells in a progenitor state (Chapter 
4). Progenitor cells within the ventricular zone give rise to both neurons during 
embryonic development, as well as glial cells after birth (Qian, et al. 2000). A specialized 
subpopulation of radial glia-like ependymal glial cells, called tanycytes, are present 
within the ventricular zone and function to modulate hypothalamic neurons based on 
cerebral spinal fluid content (Rodriguez, et al. 2005).  
 Tanycytes express progenitor markers such as Nestin and Rax, as well as Notch 
signaling components (Rodriguez, et al. 2005; Shimogori, et al. 2010; Lee, et al. 2012). 
Importantly, Nkx2.1+ cells and their linages give rise to Arc tanycytes (Yee, et al. 2009). 
We demonstrate that persistent Notch expression in Nkx2.1+ tanycytes within the Arc 
ventricular zone results in premature differentiation of these cells (Chapter 4), indicating 
that Notch may be a critical factor in tanycyte differentiation.  
 In the adult mouse, the ventral portion of the hypothalamic ventricular zone, 
termed the proliferative zone, is enriched with Notch factors. Tanycytes within this region 
give rise to adult born hypothalamic neurons (Lee, et al. 2012; Lee, Blackshaw. 2012). 
These adult born hypothalamic neurons appear to play a role in the regulation of 
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metabolism, weight and energy balance and could have important clinical significance 
(Dietrich, Horvath. 2012; McNay, et al. 2012; Lee, et al. 2012; Lee, Blackshaw. 2012; 
Haan, et al. 2013).  
 Future studies could utilize our mouse model to explore the effect of Notch on the 
function of these neurogenic cells during postnatal development and adulthood. 
Additionally, previous reports have shown that inhibiting tanycyte neurogenesis in the 
anterior hypothalamus of mice fed a high fat diet attenuated weight gain and high levels 
of activity compared to control mice (Lee, et al. 2012). Therefore, future studies could 
aim to inhibit tanycyte differentiation by injecting mice with the Notch inhibitor DAPT and 
determine if there are any effects on tanycyte function and related metabolic outcomes.  
Notch/Rbpjκ signaling, acting through Hes1, is the master regulator of Arc neuron 
differentiation  
 Previous studies have  identified genes that are necessary for specification of 
neuronal subtypes within the ventral hypothalamus, including Mash1 and Ngn3  (Li, et al. 
1996; Acampora, et al. 1999; Marin, Anderson, Rubenstein. 2000; McNay, et al. 2006; 
Pelling, et al. 2011; Anthwal, et al. 2013). However, signals that direct expression of 
these factors or directly control hypothalamic neurogenesis have not been identified.  
The work described here is the first to identify the role of Notch/Rbpjκ signaling as a 
master regulator of Arc neuron differentiation. We demonstrate that Notch/Rbpjκ 
contributes to the maintenance of Arc progenitors and is required for restraining Arc 
neuron differentiation at the expense of progenitors (Fig. 5.1; Chapter 4).  
 Future studies could confirm these findings by treating embryonic hypothalamic 
cell lines with endogenous Notch activity with the Notch inhibitor DAPT. Based on our 
results, we would expect that DAPT treatment on developing hypothalamic cells would 
downregulate Hes1 expression and increase expression of the pro-neural gene Mash1, 
resulting in an increased number of differentiated neurons. We could then attempt to 
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rescue the effects of the DAPT treatment by using siRNA to knockdown Mash1 and 
Ngn3, downstream factors repressed by Notch in our proposed pathway (see Fig 5.1), to 
determine if the phenotype resulting from DAPT treatment could be reversed.  
Notch/Rbpjκ signaling within the posterior hypothalamus 
 Notch/Rbpjκ signaling is also important for early embryonic patterning within the 
posterior hypothalamus. We found that regulated levels of Hes genes are required for 
the proper induction of infundibulum (INF), a region of the developing posterior 
hypothalamus that invaginates into the pituitary to form the posterior lobe. Increased 
levels of Hes1 and Hes5 disrupt proper hypothalamic patterning, which affects induction 
and survival of pituitary progenitors (Chapter 3). We found that NICD Tg mice as well 
Hes1 null mice both have ectopic Hes5 within the posterior hypothalamus (Chapter 3) 
and share striking similarities in pituitary malformation (Raetzman, Cai, Camper. 2007). 
A recent study reveals that ectopic Hes5 within the posterior hypothalamus is coincident 
with a lack of INF formation, hypothalamic patterning changes, as well as subsequent 
effects on pituitary development (Trowe, et al. 2013). These data further confirm that the 
spatial and temporal control of Hes genes within the hypothalamus is a crucial factor in 
proper pituitary development, including INF formation.   
 Factors that regulate the control of INF development have remained unclear until 
the studies described here. Currently, there is no molecular marker for differentiating 
glial pituicytes, the parenchyma of the developing INF, and therefore the mechanism of 
INF induction has remained a mystery. We have found that SOX9, a member of the 
SoxE group of sex-determining region-related HMG-box family  (Stolt, et al. 2003)is 
present in the developing INF at e10.5 (data not shown), and could be a marker for INF 
cells as they differentiate between e9.5 and e10.5. We demonstrate that persistent 
Notch expression increased the SOX2+ progenitor population within the posterior 
hypothalamus, which is restricted from the developing INF at e10.5 in control mice (data 
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not shown). It is possible that the ectopic Hes5 expression observed in NICD Tg mice 
and in Hes1 null mice maintains cells in SOX2+ fate and does not allow for SOX9 
expression and subsequent INF cell fate choice. In fact, SOX9 is known to determine 
glial fate within the developing spinal cord  (Stolt, et al. 2003; Stolt, Wegner. 
2010)suggesting that it may play a role in pituicyte differentiation.  
 It is not surprising that Hes genes may regulate non-neural boundaries within the 
developing hypothalamus. Hes genes are known to regulate the separation of neural 
compartments of the developing brain by boundaries, which proliferate slowly and do not 
differentiate into neurons (Kageyama, Ohtsuka, Kobayashi. 2008). The developing INF 
may act as such a boundary within the hypothalamus, as it is not immunoreactive for 
proliferative markers or SOX2 (unpublished observations).  The INF is additionally 
known to secrete morphogens such as FGF (Norlin, Nordstrom, Edlund. 2000), which is 
another characteristic of boundary regions. Importantly, Hes5 is not expressed in 
boundary regions of the CNS (Kageyama, Ohtsuka, Kobayashi. 2008), and is normally 
restricted from the posterior hypothalamus and INF by e10.5 (Chapter 3; Trowe, et al. 
2013). Therefore, ectopic Hes5 expression within the posterior hypothalamus described 
in our model may hinder cells from obtaining a SOX2-/SOX9+ INF precursor fate. Future 
studies should examine the expression of Hes5, SOX9 and SOX2 in NICD Tg mice 
before and during INF formation, at e8.5 and e9.5, to determine if ectopic Hes5 
maintains SOX2+ cells and prevents SOX2-/SOX9+ INF boundary formation.  
The studies described have not only enhanced the basic understanding of 
hypothalamic development, but also shed light on the pathogenesis of human disease 
related to developmental disruption of the hypothalamic pituitary axis. In humans, 
mutations in factors involved in hypothalamic patterning, such as Sox2 and Sox3 genes 
as well as morphogens such as SHH and FGF are associated with holoprosencephaly, 
craniofacial defects, septo-optic dysplasia and hypopituitarism (Kelly, et al. 1988; 
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Roessler, et al. 1996; Rizzoti, Lovell-Badge. 2007; McCabe, et al. 2011). The studies 
described in this dissertation demonstrate that Notch signaling can affect hypothalamic 
patterning of factors such as SOX2, FGF and SHH, suggesting that Notch may be acting 
upstream or in parallel with these pathways. Therefore, screening for regulatory 
mutations of key Notch components in patients with undefined causes of these diseases 
may identify additional genetic causes and provide potential therapeutic targets for 
clinical treatment.  
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Figures 
 
Fig. 5.1. Notch/Rbpjκ signaling, acting through Hes1, is the master regulator of 
Arc neuron differentiation. A working model of how Notch regulates Arc neuron 
differentiation, which fits into previous studies delineating the roles of other transcription 
factors, such as Mash1 and Ngn3. (Li, et al. 1996; Acampora, et al. 1999; Marin, 
Anderson, Rubenstein. 2000; McNay, et al. 2006; Chua, Jo. 2009; Pelling, et al. 2011; 
Anthwal, et al. 2013). Additionally, Hes5 has been shown to be Notch/Rbpjκ-
independent within the developing Arc (Chapter 4) and could be regulated by factors in 
the BMP (Dahlqvist, et al. 2003; Itoh, et al. 2004), TGFβ (Ross, Kadesch. 2001; Blokzijl, 
et al. 2003; Kluppel, Wrana. 2005), WNT/β-CATENIN (Axelrod, et al. 1996; Hayward, et 
al. 2005) and SHH (Wall, et al. 2009) pathways.  
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